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Abstract  
The aim of this Master’s thesis was to evaluate the hypothesis that the Saccharomyces 
cerevisiae homologs for Eukaryotic Initiation Factor 4A, TIF1 and TIF2, can be individually 
regulated. This may be an expectation if the retention of the TIF1 and TIF2 duplicates 
arises from the requirement to respond to a wide variety of cellular needs in S. cerevisiae. 
These paralogs show an almost identical sequence in their coding region (barring six 
synonymous changes in the gene sequence) but are substantially different in their 5’ and 
3’ untranslated regions that are the probable sites of regulatory functions.  To identify 
differences in use of the TIF1 and TIF2 paralogs, a dual fluorescent reporter strain 
expressing plasmid borne TIF1-RFP, incorporating the endogenous TIF1 3’ and 5’ 
untranslated regions,  and chromosomally integrated TIF2-GFP was created in order to 
probe for any differential regulation between TIF1 and TIF2. To create the fluorescent 
reporters it was necessary to learn and execute sophisticated molecular biology and 
molecular genetics which are described in this thesis. The generated fluorescence 
reporter strains were shown to be stable over multiple generations and subjected to high 
throughput and high content automated confocal microscopy.  The commercially 
available LOPAC1280 Library of Pharmacologically-Active Compounds was used to probe 
for differential regulation where a “hit” was defined as a significant change in the 
expression of at least one of TIF1-RFP or TIF2-GFP four hours after application. For TIF2p-
GFP, 2 compounds out of the 1280 library showed evidence of regulation under stringent 
thresholding criteria. For TIF1-RFP, 43 compounds were identified as regulators. There 
was no overlap of compounds. This screen provides prima-facie evidence that the TIF1 
and TIF2 are differentially regulated, as assessed by the criteria of the experimental 
system described in this thesis.  
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1 Introduction 
The study described in this thesis aims to understand the evolutionary benefit to the 
retention of two paralogous genes which produce an identical protein, eIF4A, in 
Saccharomyces cerevisiae. It is proposed that this benefit is associated with the ability to 
independently regulate the abundance of eIF4A in response to cellular needs through the 
paralogous genes.  A fluorescence-based reporter strain has been constructed to test this 
hypothesis, which has been evaluated though treatment of the reporter strain with small 
molecule perturbants. 
The role of eIF4A is presented below, specifically its position within the superfamily of 
RNA helicases and the initiation of translation.  This study sits within a wider programme 
of evaluation of the role of the duplicate genes for eIF4A in yeast, and so the principles of 
gene duplication are introduced and the implications relating to eIF4A and translation are 
discussed. 
1.1 RNA helicases and the DEAD box proteins. 
1.1.1 RNA helicases 
Enzymes that use ATP to bind or remodel RNA and RNA-protein complexes are termed 
RNA helicases, and are involved in almost all aspects of RNA metabolism, from 
transcription and translation to mRNA decay (Linder and Jankowsky 2011). A classification 
system established by Gorbalenya and Koonin, sorts both RNA and DNA helicases into 
superfamilies based on the occurrence and characteristics of conserved motifs in their 
primary sequence (Gorbalenya and Koonin 1993; Cordin, Banroques et al. 2006). 
Although the structural conservation within each superfamily is high, two distinct types of 
helicases exist which divide the superfamilies; those that form multimeric ring-like 
assemblies as seen in superfamilies 3-6, and those which do not form rings, superfamilies 
1 and 2 (SF1 and SF2) (Fairman-Williams, Guenther et al. 2010). The families which make 
up SF1 and SF2 are illustrated in Figure 1.1.  
SF1 and SF2 helicases are characterised by the presence of at least 12 consensus 
sequences motifs situated around a highly conserved core region of two virtually identical 
domains resembling the bacterial recombination protein recombinase A (RecA) (Linder 
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and Jankowsky 2011). Sequence conservation across both superfamilies is at its highest in 
the residues between the two RecA like domains which coordinate ATP binding and 
hydrolysis (motifs I, II and VI) (Rocak and Linder 2004); (Jankowsky, Guenther et al. 2011). 
 
 
Figure 1.1: The families of SF1 and SF2.Families containing only RNA helicases are 
marked with a circled R, all other families include DNA helicases as well as RNA helicases. 
The oval represents uncertainty in the topology. Figure from Jankowsky 2011 (Jankowsky, 
Guenther et al. 2011). 
 
1.1.2 DEAD box protein family of helicases 
First described by Linder and Slonimski, the DEAD box protein family of RNA helicases are 
the largest sub class of Superfamily 2 (SF2) (Linder and Slonimski 1988; Linder and 
Slonimski 1989) and, although known to bind DNA, are the only family to contain 
exclusively RNA helicases. Although DEAD box proteins have been found in bacteria and 
archaea they are most prevalent in eukaryotes (Rocak and Linder 2004) and are directly 
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involved in nuclear transcription, pre mRNA splicing, and ribosome biogenesis (de la Cruz, 
Kressler et al. 1999). Dead Box proteins are characterised by the presence of at least 12 
consensus sequences /conserved motifs in the core region and notably it is the presence 
of the amino acid sequence D-E-A-D in Motif II (or Walker B motif) from which their name 
is derived (Linder 2006; Linder and Jankowsky 2011). This core region is flanked by N and 
C terminal extensions with varying length and composition (Cordin, Banroques et al. 
2006). Moreover, the core region maintains ATP dependent RNA helicase activities, whilst 
the flanking regions provide additional interactions with substrates and cofactors leading 
to the substrate specificity and wide functional variation of the DEAD box family (Benz, 
Trachsel et al. 1999; de la Cruz, Kressler et al. 1999; Rocak and Linder 2004). 
Eukaryotic Initiation Factor 4A (eIF4A), one of the most abundant proteins in many cell 
types (Linder and Jankowsky 2011), is the archetypical DEAD box protein representing the 
minimum core helicase elements common to all DEAD box proteins (Benz, Trachsel et al. 
1999; Rocak and Linder 2004). It is generally accepted that eIF4A has a major function in 
the translation initiation process. 
1.2 Translation initiation and eIF4A 
Translation, the conversion of genomic information from mRNA into an amino acid 
sequence, matured and folded into protein, can be sub divided into three major sections; 
initiation, elongation, and termination (Sonenberg and Hinnebusch 2009). 
1.2.1 Translation Initiation 
The initiation phase, the rate limiting step of translation (Lackner and Bähler 2008), 
involves recruitment of the 40S ribosomal subunit at the initiator AUG codon and the 
subsequent assembly of a translational /elongation competent 80S ribosome with the 
union of the 40S and 60S ribosomal subunits (Lackner and Bähler 2008). The initiation 
phase, for most eukaryotic mRNAs, is a highly conserved process catalysed by at least 11 
eukaryotic initiation factors (eIFs), many of which form multi-protein complexes with up 
to a minimum of 25 proteins (Berthelot, Muldoon et al. 2004). The process is currently 
best described by the scanning model proposed by Kozak and Shatkin (Kozak and Shatkin 
1978; Kozak 1999). 
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1.2.2 Cap dependent initiation 
The scanning model (illustrated in Figure 1.2) is a cap dependent process that outlines 
initiation from the interactions of the 40S ribosomal subunit with mRNA through to 
generation of an 80S ribosome competent for polypeptide chain elongation. 
 
Figure 1.2: The scanning model of cap dependent translation initiation. Figure adapted 
from de la Cruz et al (1999) and Altman et al (2010). 
 
The process of scanning begins before any ribosomal input with recognition of a 5’ 
terminal modification, the 7-methylguanosine (m7GpppN or m7G) cap structure, on the 
mRNA by the eIF4F complex which consists of three components eIF4E, eIF4G and eIF4A. 
The cap binding protein eIF4E is responsible for the direct interaction with the 
aforementioned cap structure and is held in position near the mRNA through the 
duration of the scanning for the AUG codon by the scaffolding protein eIF4G.  
For successful scanning, the initiation procedure requires an unfolded section of mRNA 
which is often not the lowest energy conformation.  Subsequently any and all secondary 
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structures present in the leader mRNA must be removed.  Unwinding and/or 
rearrangement of the duplex mRNA in the 5’ UTR (5’ untranslated region) are mediated 
by eIF4A’s ability to “melt” the secondary structure with its ATP dependent RNA helicase 
activity. However, eIF4A has low affinity for RNA (in vitro) hence, the RNA stimulated 
ATPase and unwinding activities shown by eIF4A have been described as low (Linder and 
Jankowsky 2011). Furthermore, Rogers, Richter et al (2001) illustrated that the RNA 
helicase activity observed during translation initiation can be stimulated by co factors 
eIF4B, eIF4H, or as a constituent of the eIF4F complex.  
The scaffolding protein eIF4G has been proposed to promote translation through mRNA 
circularisation. The interactions of eIF4G with both the cap bound eIF4E and poly (A) 
binding protein (PABP), which associates with the 3’ poly (A) mRNA tail, cause mRNA 
pseudo-circularisation which may provide a framework for a closed loop model of 
translation (Lackner and Bähler 2008; Kronja and Orr-Weaver 2011). A closed loop model 
would explain how known regulatory elements of translation that are found in the 3’ UTR 
are able to effect translation despite the fact that this process starts at the far end of the 
mRNA (Wilkie, Dickson et al. 2003; Lackner and Bähler 2008). Additionally, PABP interacts 
with eIF4B, resulting in suggestions that this interaction leads to stimulation of  the  
PABP - poly (A) mRNA tail interaction as well as stimulation of eIF4A’s helicase activity 
(Wilkie, Dickson et al. 2003). 
The interaction of eIF4F with the mRNA, as well as the possible influence of mRNA  
pseudo- circularisation, activates the mRNA allowing the scanning process to commence. 
Activation allows the binding of a preassembled 43S preinitiation complex (PIC), which in 
mammals is shown to interact with eIF4G (Lackner and Bähler 2008), to the mRNA near 
the m7G cap structure (Sonenberg and Hinnebusch 2009). The PIC, which consists of 
several eIFs including eIF2 and eIF3 and the 40S ribosomal subunit loaded with an 
initiator methionyl-tRNA (Met-tRNAi), then scans the 5’ UTR, in the 5’ to 3’ direction, 
searching for the AUG start codon that matches the loaded Met-tRNAi (Mendez and 
Richter 2001). Upon the discovery of this start codon the release of several eIFs is 
triggered which allow the recruitment of the large 60S subunit and subsequent formation 
of the 80S ribosome. This 80S ribosome formation signals the end of the initiation process 
prompting the start of the elongation phase (Sonenberg and Hinnebusch 2009). 
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1.2.3 Cap independent Initiation 
Although cap dependent translation initiation is the most common for cellular mRNAs, 
there are a subset of eukaryotic mRNA which can circumvent the scanning process, 
initiating translation through the use of internal ribosomal entry sites (IRES) (Lackner and 
Bähler 2008; Sonenberg and Hinnebusch 2009). IRES have been described as  
cis-regulatory elements which contain no obvious consensus sequence. Present in  the 5’ 
UTR these elements achieve translation initiation independently of the interactions of 
eIF4F with mRNA, hence the term cap independent translation (Kronja and Orr-Weaver 
2011). IRES elements are common in viral mRNAs allowing the continuation of their 
translation when the eIFs required for cap dependent translation are inhibited 
(Sonenberg and Hinnebusch 2009). In contrast, yeast IRES elements are far less prevalent 
and it is unknown whether this mechanism is commonly used to initiate translation in any 
yeast mRNA’s (Zhou, Edelman et al. 2001).  One such circumstance where cap 
independent initiation has proven crucial is in the observed function of the URE2 gene. 
The URE2 IRES element is able to produce a second, shorter form of Ure2p than that 
which is produced by cap dependent initiation. This IRES element is necessary as the two 
protein forms act with different functions; the shorter protein in nitrogen assimilation 
and the longer in the formation of prion like aggregates (Reineke and Merrick 2009). 
1.2.4 Translation initiation and eIF4A in Saccharomyces cerevisiae 
Saccharomyces cerevisiae, brewer’s or baker’s yeast,  is considered to be a model 
eukaryotic organism because of its small size, rapid doubling time, haploid/diploid life 
cycle and economically favourable conditions for growth (Gershon and Gershon 2000). 
Furthermore, S. cerevisiae’s comparatively simple genome, genetic tractability and range 
of unparalleled genetic tools which can be applied, such as the yeast genome deletion 
sets (YGDS)  and yeast GFP clone collection (Winzeler, Shoemaker et al. 1999; Tong, 
Evangelista et al. 2001; Huh, Falvo et al. 2003; Tong and Boone 2006), make it a model 
organism for use throughout this study.   
1.2.4.1 Translation Initiation and eIF4A 
Translation initiation is a highly homologous process between the mammalian and yeast 
systems. However similar the proposed function of eIF4A during both derivatives of 
initiation, there are subtle differences in how eIF4A is believed to achieve its function. In 
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order for eIF4A to contribute its helicase activity in either system, an association between 
eIF4A and mRNA needs to be established. However, this is not the only association eIF4A 
is able to make and during translation initiation eIF4A can be considered in two forms 
when associated with mRNA; either free of further interactions or bound in the eIF4F 
complex following interaction with eIF4E and eIF4G (Lanker, Müller et al. 1992).  
In the free form of eIF4A, the helicase activity proceeds bi-directionally, from either  5’ to 
3’ or 3’ to 5’, with no bias (Rogers, Komar et al. 2002). In addition, whilst in this form 
eIF4A is considered to be a non processive helicase meaning the average number of base 
pairs unwound per helicase binding event is considered low (Rogers, Richter et al. 2001; 
Betterton and Jülicher 2005). As part of the eIF4F complex, the helicase activity of eIF4A, 
and its subsequent function in translation initiation, improves, becoming processive 
(higher average number of base pairs unwound per helicase binding event) as well as 
proceeding uni-directionally in the 5’ to 3’ direction (Rogers, Richter et al. 2001; Linder 
and Jankowsky 2011).  
Until recently, it was believed that unlike mammalian eIF4A, yeast eIF4A was only found 
in the free form as eIF4A could not be co-isolated with the remaining components of 
eIF4F: eIF4E and eIF4G (Rogers, Komar et al. 2002; Schutz, Bumann et al. 2008). There is 
low homology between mammalian and yeast eIF4G, of particular interest is a domain 
present in the C terminal region of mammalian eIF4G that yeast eIF4G lacks. In 
mammalian systems this region includes a second eIF4G-eIF4A binding site which has 
been suggested as a possible requirement for stable inclusion of eIF4A in the eIF4F 
complex (Dominguez, Kislig et al. 2001). However, crystal structures of core regions of 
yeast eIF4G interacting with full length yeast eIF4A have since been obtained illustrating 
both free and bound forms are crucial for translation initiation in both the yeast and 
mammalian processes (Schutz, Bumann et al. 2008). 
As previously stated, mammalian eIF4A activity can be stimulated by the presence of 
eIF4B and eIF4H (Rogers, Richter et al. 2001). However in yeast, this increase in 
processivity, as a result of stimulation, is not as well defined. The yeast eIF4B homolog 
(encoded by TIF3), is non-essential for cell viability and its role in translation initiation is 
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unclear, furthermore there is no known homolog of eIF4H seen in yeast (Altmann and 
Linder 2010).  
1.2.4.2 Homology of eIF4A 
The yeast DEAD box protein family, in contrast to the mammalian, is much smaller, 26 
and 37 members respectively (Linder and Jankowsky 2011). However, as testament to 
their required functions, most yeast DEAD box proteins have conserved counterparts in 
higher eukaryotes (Linder 2006). Mammalian systems encode for three isoforms of eIF4A: 
eIF4AI and eIF4AII which are involved in translation initiation and eIF4AIII which is 
involved in the non-sense mediated decay (NMD) pathway. The yeast homolog of 
mammalian eIF4A, first isolated as a suppressor of a mitochondrial missense mutation, is 
encoded by the paralogous genes TIF1 and TIF2 (Linder and Slonimski 1989). These 
paralogs show an almost identical sequence in their coding region (barring six 
synonymous changes in the gene sequence) and both encode for an identical 395 amino 
acid protein (Linder and Slonimski 1988). At the protein level, yeast eIF4A shares a 66% 
overall identity and 82% amino acid sequence similarity with its mammalian homolog 
(Dominguez, Kislig et al. 2001). Despite this high homology mammalian eIF4A cannot 
substitute for the yeast factor in vivo and is not functional in a yeast in vitro translation 
system (Dominguez, Kislig et al. 2001). Furthermore, although mammalian eIF4A cannot 
rescue yeast in the absence of yeast eIF4A, rescue has been observed between eIF4A of 
the murine and drosophila systems (Altmann and Linder 2010). 
Whilst the sequence identity across all eukaryotes of eIF4AIII to the other isoforms is 
65%, the sequence identity of eIF4AI and eIF4AII is as high as 90-95%. However similar 
these two proteins are, they remain functionally distinguishable as illustrated by the 
existence of differing expression patterns between tissues (Rogers, Komar et al. 2002). In 
contrast to other eukaryotes, currently TIF1 and TIF2 have not been proven to be 
functionally distinguishable (Linder and Slonimski 1989). This retention of protein 
sequence and apparent retention of function between a pair of duplicates is unusual, and 
understanding its importance in yeast eIF4A is an underlying motivation for the research 
presented in this thesis.  
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1.3 Duplicate genes 
1.3.1 The need for duplication 
The theory of evolution by gene duplication, although its technicalities are debated by 
many evolutionary geneticists, is considered a general principle of biological evolution 
(Zhang 2004). Gene duplication provides raw genetic material which can be adapted for 
functional innovation, implying new genes are not constructed de novo but are co-opted 
from existing genes (Conant and Wolfe 2008). A functional bias for the retention of 
duplicated genes which function as transcription factors, kinases, particular enzymes and 
transporters has been identified in a variety of organisms including humans and yeast 
(Conant and Wolfe 2008). In S. Cerevisiae the retention rate of ribosomal proteins 
highlights this functional bias as 59 of the 78 duplicate gene pairs have retained two 
copies (Komili, Farny et al. 2007). Amongst these are components of the yeast translation 
initiation machinery other than eIF4A, which is  produced by the paralogous genes TIF1 
and TIF2, such as the homolog of eIF4G which is produced by the duplicate genes TIF4631 
and TIF4632. 
1.3.2 Duplication methods 
Duplication events can occur on two scales; small scale duplication (SSD), which is a 
continuous process involving a single gene or a small pool of genes; or whole genome 
duplication (WGD) (Davis and Petrov 2005; Conant and Wolfe 2008). Although rare, WGD 
is postulated to have played a major role in the evolution of different species such as the 
vertebrate lineage and has been attributed to shaping the facultative anaerobic lifestyle 
of the Saccharomyces lineage (Cliften, Fulton et al. 2006).  
Although both these duplication processes involve gene duplication, the likelihood of 
fixation of the newly duplicated gene or genes in the genome and subsequent 
preservation of both gene duplicates by divergence of gene function, differs between 
them (see Figure 1.3). While SSD requires an independent mutation event followed by 
selective pressure to fix the gene in the genome, WGD is characterised not by 
independent mutations but duplication with the entire genome. Subsequently, genes 
deemed to be advantageous are not immediately fixed in the genome, like after SSD 
events, but must survive the period of genome shrinkage that follows WGD to eliminate 
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functional redundancy (Davis and Petrov 2005). As a result of these procedural 
differences, gene duplication via SSD or WGD presents differing evolutionary 
opportunities (Conant and Wolfe 2008). 
 
Figure 1.3: The process leading to long-term duplicate survival. Figure adapted from 
Davis and Petrov (2005). 
1.3.3 Gene functional bias 
Genes duplicated by either SSD or WGD, at the time of duplication, present similar levels 
of codon bias to each other, which are in favour of higher levels of gene expression, as 
well as a tendency to arise from slowly evolving genes, however, the two duplicate sets 
are enriched for different functional classes of genes  (Davis and Petrov 2005; Conant and 
Wolfe 2008). Compared with proteins retained after SSD, those proteins retained after 
WGD events more strongly retain the  aforementioned bias towards higher-expression 
favouring codon bias (Conant and Wolfe 2008), show lower frequency of essential genes 
and have a higher synthetic lethality rate thus indicating that the duplication is not 
contributing to robustness through direct back-up of functionality (Guan, Dunham et al. 
2007). Moreover, WGD events result in proteins that diverge more in their expression 
pattern and upstream regulatory region than duplicates retained from SSD, implying their 
role in fine tuning expression levels (Guan, Dunham et al. 2007). Independent of 
sequence similarity, paralogous genes from WGD share more protein interactions and 
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biological functions than SSD duplicates (Guan, Dunham et al. 2007; Conant and Wolfe 
2008). 
As previously stated, a functional bias for the retention of certain duplicated genes exists. 
Davis and Petrov (2005) were among the first researchers to investigate gene expression 
of duplicates generated by SSD or WGD and were able to propose a cause for some of 
this functional bias. They reported WGD as showing enrichment in ribosomal proteins in 
contrast to SSD which showed a lack of transcriptional regulator proteins and 
overabundance of enzyme regulator proteins. The ‘dosage balance hypothesis’, 
supported by the types of genes and gene functions resulting from both WGD and SSD, 
has been postulated as a possible explanation for this duplication scale-dependent 
functional divergence (Conant and Wolfe 2008).  
1.3.3.1 Dosage Balance Hypothesis 
Evolution via duplication may provide genes with novel functions adaptable to the 
genome; however, these adaptations can become precluded if the initial duplication 
event is selectively disadvantageous to the genome. This notion that duplication might 
interfere with highly constrained cellular systems and hence be selectively unfavourable 
is termed the ‘dosage balance hypothesis’ (Conant and Wolfe 2008). In order to retain 
these so called duplication-resistant genes post duplication, the environmental 
stoichiometry must be maintained.   
One way of achieving this is to regulate the stoichiometry at the genomic level. The 
stoichiometric environment of the genome is changed drastically in SSD compared with 
WGD which maintains the stoichiometry ratio as the size of the genome doubles. The 
stoichiometric environment becomes critically important when genes are inherently 
expressed in a specific ratio with other loci; either as a result of their involvement in a 
multi-protein complex or function in a biochemical pathway, and a deviation from this 
stoichiometry may be catastrophic (Davis and Petrov 2005). As such duplication-resistant 
genes are unlikely to become fixed in the genome after SSD but are likely to become fixed 
after WGD because of the deleterious effects on the genome if gene function is not 
maintained (Davis and Petrov 2005; Conant and Wolfe 2008). The other alternative is to 
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compensate for the imbalance in gene dosage by regulation of protein expression 
through transcriptional / translational regulation, mRNA degradation and the like.  
1.3.4 Surviving duplication – Gene fixation 
Complete redundancy between duplicated genes is evolutionarily unfavourable and there 
are many possible and more favourable evolutionary fates these genes can take (Musso, 
Costanzo et al. 2008). 
One of the copies may be redundant, accumulate deleterious mutations leading to 
development of a non-functional pseudogene. If the ancestral gene will benefit at a 
higher gene dosage natural selection will allow for functional preservation of both 
duplication genes. Upon preservation the paralogous genes may functionally diverge via 
two commonly accepted pathways: Neofunctionalisation, considered the classic scenario, 
where the ancestral gene function is maintained in one of the paralogous genes whilst 
the other evolves a new biochemical function; Subfunctionalisation, the partitioning of 
ancestral gene functions between the paralogous genes so that their joint 
function/activity is equal to that of the ancestral gene (Marques, Vinckenbosch et al. 
2008). 
1.3.5 Genetic redundancy  
When subjected to genetic perturbations or external stimuli the cellular constituents of 
an organism may change. It is the fundamental property of all living systems to attempt 
survival of such changes. The lack of change to phenotypic variations is termed ‘genetic 
robustness’ (Borenstein and Ruppin 2006). In certain cases, an organism’s ability to 
demonstrate genetic robustness has proven to reduce its susceptibility to mutations such 
as protein tolerance to amino acid substitutions, gene dispensability in yeast, and the 
error tolerance of complex biological networks.  Subsequently, if the consequences 
attributed to such mutations are left unresolved, the result could be disastrous for cell 
viability (Borenstein and Ruppin 2006).   
Duplicate gene pairs can provide an organism with an added level of genetic robustness 
as a consequence of the duplication process.  As previously stated (section 1.3.4), 
duplicate genes can endure many different evolutionary fates. Of these, fates which 
result in the partitioning of ancestral function between paralogous genes may provide 
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the genome with genetic redundancy (Louis 2007). Genetic redundancy is the ability of 
gene A to “back-up” the gene function usually attributed to gene B, or with reference to 
duplicate genes, the ability of one gene, in the absence/inactivation of its paralogous 
gene, to provide the function usually generated by the paralogous gene (Meyer 2003).  
Accordingly, genetic redundancy following duplication is only possible because 
paralogous genes evolve from a single gene with a shared function and potentially still 
retain some level of functional overlap. For example one third of all surveyable WGD 
duplicates have retained the ability to buffer for the loss of their respective paralogous 
gene under standard laboratory growth conditions (Musso, Costanzo et al. 2008). 
Furthermore, the protection offered by duplicate genes is believed to gradually attenuate 
over evolutionary time as their sequences diverge and the functional overlap reduces 
(Brookfield 2003).  
In contrast, there are examples of duplicate gene pairs which have retained their 
functional overlap over an extended evolutionary period or even speciation; such is the 
case for the yeast genes ARE1/ARE2 and the mammalian homologs  ACAT1 and ACAT2. 
Subsequently it has been suggested that redundancy may form a part of a larger 
regulatory network (Kafri, Levy et al. 2006). 
Genetic redundancy presents a major hurdle for researchers trying to elucidate the 
function of a particular gene as the application of standard techniques may not have a 
noticeable effect due to the functional substitution of the duplicate gene (Meyer 2003). 
An illustration of this comes from research of Rotenberg who, using knock out (KO) 
technologies, was investigating whether duplicate ribosomal protein genes were 
functionally distinct. Rotenberg concluded that duplicate ribosomal proteins where 
functionally redundant and the only difference observed was that the more highly 
expressed duplicate played a more significant cellular role (Rotenberg, Moritz et al. 
1988). However, recent studies present evidence for gene specific defects among 
paralogous genes including defects in sporulation, actin organisation and bud site 
selection. Thus illustrating a much more complex relationship challenging this conclusion 
as well as demonstrating the flaw in directly attributing growth rate to observed function 
(Komili, Farny et al. 2007). 
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1.3.6 Duplication in S. cerevisiae   
1.3.6.1 Ancient Gene Duplication 
The S. cerivisiae genome is believed to have formed from an ancient round of whole 
genome duplication approximately 100 million years ago (Davis and Petrov 2005). After 
genomic restructuring, shrinkage and preservation of the functionally evolved genes, 
approximately 5770 genes remained in the genome of which it is thought only 10 – 11 % 
of the duplicated genes were maintained (Cliften, Fulton et al. 2006; Komili, Farny et al. 
2007). Evidence for an ancient WGD event was first proposed by Wolfe and Shields who 
identified 55 duplicate regions, encapsulating 376 pairs of homolog genes with an 
average amino acid sequence similarity of 63% (Wolfe and Shields 1997). Regions (or 
blocks), were identified in 70% of the genome and Wolfe and Shields concluded  the 
resulting pattern of duplicates identified in the genome was statistically unlikely to form 
via SSD rather than WGD (Wolfe and Shields 1997; Kellis, Birren et al. 2004; Cliften, Fulton 
et al. 2006).   
Of particular interest to this study, is the 41st block defined by Wolfe and Shields which 
identified regions of homology between sequences of chromosomes X and XI, which bear 
the genes TIF1 and TIF2 respectively. Although unwise to assume without knowledge of 
the gene functions of the ancient genome, it seems plausible that TIF1/TIF2, as well as 
their three nearest chromosomal neighbours; RPS21A/ RPS21B (small ribosomal 
subunits), GLG1/GLG2 (initiators of glycogen synthesis), and YUR1/KTR2 
(mannosyltransferases involved in N linked protein glycosylation), are all examples of 
gene preservation from subfunctionalisation (SGD. 2012).  
1.4 Regulation of protein synthesis 
The regulation of protein expression can be separated into regulation of gene expression, 
be it transcriptional or posttranscriptional control, or regulation of the proteins 
themselves by posttranslational modification and protein degradation (Lackner and 
Bähler 2008).  
However, as previously stated, the duplicate genes TIF1 and TIF2 convey almost identical 
sequence similarity in their coding regions (six synonymous changes) and both encode for 
an identical protein. Subsequently, regulation at the protein level here, will 
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indistinguishably affect both genes’ identical protein products. Furthermore, as literature 
suggests that complete redundancy between gene pairs is evolutionary unfavourable 
(Musso, Costanzo et al. 2008) it is essential, in order to avoid complete gene redundancy, 
that differential regulation of TIF1 and TIF2 be achieved at the gene level.  
It is well established that gene expression is regulated at multiple levels which include 
transcription, RNA processing/export, translocation and translation (Lackner and Bähler 
2008). Transcriptional regulation can be achieved at many stages throughout the 
transcript’s lifetime. Instances include co-transcriptional modifications such as addition of 
the m7G cap, splicing of introns out of pre-mRNA to generate functional mRNA and 
polyadenylation. In contrast to transcriptional regulation, translation regulation permits 
for more rapid changes in expressed protein concentrations making it a suitable method 
for maintaining cellular homeostasis (Sonenberg and Hinnebusch 2009). As previously 
described (see section 1.2) there are three main phases of translational control, all of 
which have potential targets for regulation. Due to a relative plethora of proteins and 
initiation factors involved at the initiation phase, it is the initiation phase where most of 
the translation regulation occurs (Lackner and Bähler 2008). Regulational events during 
translation are usually reversible as they are often mediated through reversible protein 
modifications such as phosphorylation of initiation factors (Sonenberg and Hinnebusch 
2009). 
Although TIF1 and TIF2 have a high sequence similarity, it is of particular interest that to 
note that their flanking UTRs bear almost no similarity. Furthermore, although many 
features of mRNA contribute to translation, it has been suggested that most control 
elements are located within the untranslated regions (Wilkie, Dickson et al. 2003), 
including transcription factors and cis regulatory elements. For example, iron regulatory 
proteins (IRPs) which recognise a stem loop structure known as the iron response 
element (IRE) are contained in the 5’ UTR. In response to intracellular iron concentration 
this interaction, depending on the location of the IRE in the 5’ UTR, can act to either 
inhibit the 40S ribosomal protein binding the mRNA or impede the scanning mechanism 
of the pre-initiation complex (Wilkie, Dickson et al. 2003). Contained in the 3’ UTR are the 
3’ UTR transcript localisation motifs which are crucial for the development of several 
organisms across the evolutionary spectrum. These motifs regulate mRNA localisation to 
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discrete sites allowing the controlled synthesis of proteins at target locations and 
production of morphagen gradients (Farooq, Choi et al. 2012). 
In many mRNA AU-rich elements (AREs) are present in the 3’ UTR and accompanied by 
their specific ARE-binding proteins are able to influence gene expression through mRNA 
turnover and translation. One such example is the ARE-binding proteins of the AUF1 
family which promote the degradation of mRNA encoding cytokines or cell cycle 
regulators as well as inducing translation of MYC proto-oncogene mRNA (Lackner and 
Bähler 2008). Studies in human RKO colorectal carcinoma cells illustrated that the ARE-
binding protein TIAR, in response to ultra violet radiation, binds the 3’ UTR of eIF4A and 
eIF4E, potentially suppressing their translation (Mazan-Mamczarz, Lal et al. 2006). A 
protein-protein BLAST search of TIAR indicates the closest yeast ortholog is PUB1 which is 
a Poly (A) and RNA binding protein that binds many mRNA and is required for mRNA 
stability. This, however, was not a full sequence overlap and alignment score of 26 
(where alignment score is the number of identities between the two sequences, divided 
by the length of the alignment, and represented as a percentage) was generated by 
ClustalW alignments. Although, in the aligned sequences where they are most common 
they share a 41% identity and 60% sequence similarity.  
1.5 Aims and Objectives 
1.5.1 Aims 
The primary aim of this study was to evaluate whether TIF1 and TIF2 can be individually 
regulated by small molecule intervention. 
This aim fits into broader programmes; 1) To understand the evolutionary benefit to the 
retention of two genes producing an identical eIF4A protein in S. cerevisiae; and 2) to 
evaluate the potential for small molecule regulation of translation for therapeutic 
intervention in yeasts or potentially other eukaryotes. 
The strategy employed to identify differential regulation between TIF1 and TIF2 was to 
construct a dual fluorescent probe where either a red or green fluorescent protein (RFP 
or GFP) marker was fused to the coding region of TIF1 or TIF2. This creates a functional 
reporter strain with distinguishable TIF1 and TIF2 markers that can be used to identify 
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their respective gene functions in a variety of cellular conditions. To encompass as many 
different variables as possible the dual fluorescent reporter was subjected to a 
morphological high throughput screening (HTS) utilising the LOPAC1280 Library of 
Pharmacologically-Active Compounds, chosen as a library of environmental variables 
rather than as a library of bio-actives of interest.  
We hypothesise that retention of the TIF1 and TIF2 duplicates arises from the need to 
respond to a wide variety of cellular needs in S. cerevisiae. These may include 
environmental and nutrient stresses or cell cycle requirements. These may be responded 
to by the up regulation or suppression of total eIF4A through one of the TIF genes or 
through regulation of the stability or localisation of a specific TIF mRNA. Discovery of 
small molecule regulators of TIF1p or TIF2p will provide molecular tools for further 
understanding of this system. 
1.5.2 Experimental Objectives 
1) Creation of a TIF1-RFP fusion protein 
2) Utilisation of commercially available TIF1-GFP and TIF2-GFP yeast strains and the 
generated TIF1-RFP fusion protein in the construction of a dual fluorescent 
reporter strain capable of distinguishing between the duplicate genes TIF1 and 
TIF2 
3) Developing the methodology for the use of these fluorescent reporters in high 
throughput screening 
4) Screening of the LOPAC1280 Library of Pharmacologically-Active Compounds with 
the commercially available single TIF1-GFP and TIF2-GFP strains using high 
throughput confocal microscopy  
5) Screening of the LOPAC1280 Library of Pharmacologically-Active Compounds with 
the dual fluorescent reporter stain using high throughput confocal microscopy 
6) Cheminformatic analysis of the compounds identified in the high throughput 
screens. 
These objectives will address the aim through identification of lead compounds for 
further study.  Extensive validation and determination of the pathways through which 
TIF1 and TIF2 are regulated is beyond the scope of this Masters project.  
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2 Methods 
2.1 Materials and Equipment 
2.1.1 Reagents 
The amino acids including monosodium glutamate (MSG, L-glutamic acid sodium salt 
hydrate) were purchased from Sigma-Aldrich (Auckland, New Zealand); Bacto Peptone, 
Bacto Triptone, Bacto Yeast Extract, and Bacto Yeast Nitrogen Base were purchase from 
DIFCO (Detroit, MI, USA). D-Glucose (Dextrose) was purchased from Fisher Scientific 
(Auckland, New Zealand) and was dissolved in water to a concentration of 40% (w/v), 
then autoclaved and stored at room temperature. As required, D-Glucose was and added 
to medium to a final glucose concentration of 2% (w/v). 
Unless stated otherwise, all other reagents were sourced from Sigma-Aldrich (Auckland, 
New Zealand).  
2.1.2 Chemical libraries and individual chemicals 
The LOPAC1280 Library of Pharmacologically-Active Compounds (LOPAC library) was 
purchased from Sigma-Aldrich (Auckland, New Zealand). The LOPAC library was originally 
arranged in 96-well, one compound per well format covering 16 plates. However, a 
working stock set of the LOPAC library which had previously been diluted in DMSO, from 
10 mM to 1 mM, was employed in this study.  
In addition to the LOPAC library, two research compounds also diluted in DMSO to 1 mM, 
DD1 and DD2 were employed in this study. DD1 and DD2 were kindly gifted by Dylan 
Davies from the School of Biological Sciences, Victoria University of Wellington. DD1 and 
DD2 were screened in tandem with the LOPAC library as both were added to the library 
at the expense of two separate internal control wells , maintaining each plate’s border 
control. 
2.1.3 Yeast strains 
All deletion strains were purchased from Thermo Scientific-Open Biosystems (Huntsville, 
AL, USA) as a part of the YKO MATa Strain Collection and have the genotype 
XXXΔ::KANMX4, his3Δ1, leu2Δ0, met15Δ0 and ura3Δ0  (Winzeler, Shoemaker et al. 1999).   
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Strains bearing the green fluorescent protein fusions were purchased from Invitrogen 
(Carlsbad, CA, USA) as part of the Yeast GFP Clone Collection (Huh, Falvo et al. 2003). 
Strains of this collection are of the MATa mating type which has a genotype 
 XXXGFP-HIS3MX6, his3Δ1, leu2Δ0, met15Δ0, and ura3Δ0.  
Strains of S. cerevisiae utilised in the construction of the dual fluorescent probe were of 
the MATa mating type of the BY4741 background which have a genotype of  
his3Δ1, leu2Δ0, met15Δ0 and ura3Δ0.  
Two dual fluorescent constructs were assembled during this study; TIF1-GFP, TIF2, TIF1-
RFP which has the genotype MATa, tif2Δ::KANMX4, his3Δ1, leu2Δ0, met15Δ0, ura3Δ0, 
TIF1-GFP-his3.MX6, pRS316-URA3 TIF1-RFP, as well as the construct TIF2-GFP, TIF1, TIF1-
RFP which has the genotype MATa, tif1Δ::KANMX4, his3Δ1, leu2Δ0, met15Δ0, ura3Δ0, 
TIF2-GFP-his3.MX6, pRS316-URA3 TIF1-RFP. 
2.1.4 Growth media 
Yeast strains used in this study were cultured according to standard yeast methods 
(Amberg and Burke 2005) in one of the following media:  
2.1.4.1 Yeast Peptone Dextrose (YPD) 
YP medium was prepared according the following recipe: 8 g yeast extract, 16 g Bacto 
Peptone, and 0.096 g adenine were mixed into 760 mL of distilled water and sterilized by 
autoclaving; 40 mL of 40% glucose solution was added. G418 was added at a final 
concentration of 200 μg/ml when required. 
2.1.4.2 Synthetic Complete (SC) 
Synthetic Complete (SC) medium was prepared using the following recipe: 1.7 g of Bacto 
Yeast Nitrogen Base (without amino acids or ammonium sulphate), 1 g of MSG, and 2 g of 
“amino acid supplement powder mix” were mixed into 760 mL of distilled water and 
sterilized by autoclaving; 40 mL of 40% glucose solution was added. G418 was added at a 
final concentration of 200 μg/ml when required.  
 “Amino acids supplement powder mix” contains: 3 g adenine, 2 g uracil, 2 g inositol, 0.2 g 
para-aminobenzoic acid, 2 g alanine, 2 g arginine, 2 g asparagine, 2 g aspartic acid, 2 g 
cysteine, 2 g glutamic acid, 2 g glutamine, 2 g glycine, 2 g histidine, 2 g isoleucine, 10 g 
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leucine, 2 g lysine, 2 g methionine, 2 g phenyalanine, 2 g proline, 2 g serine, 2 g threonine, 
2 g tyrosine, 2 g tryptophan, and 2 g valine. 
2.1.4.3 Synthetic Dropout (SD) 
Drop-out (DO) powder mixture is a combination of the listed ingredients for SC media 
minus the appropriate supplement; 2 g of the DO powder mixture is used per litre of 
medium. 
SD –URA (synthetic dropout missing uracil): as for SC medium but without uracil in the 
“amino acid mix”; glucose added at final concentration of 2% (w/v).  
SD –HIS (synthetic dropout missing histidine): as for SC medium but without histidine in 
the “amino acid mix”; glucose was added at final concentration of 2% (w/v).  
2.1.5 Bacterial growth media 
All bacteria were cultured at 37 °C overnight in Luria Bertani (LB) media supplemented 
with 100 µg/ml of ampicillin. 
2.1.5.1 Luria-Bertani (LB) 
LB medium was prepared according to the following recipe: 10 g Bacto Tryptone, 5 g 
Bacto Yeast Extract, and 10 g NaCl were mixed into 800 mL of distilled water and the pH 
adjusted to 7.5 with 1 M NaOH solution. The volume was finally adjusted to 1 L with 
distilled water, the medium sterilized by autoclaving and stored at room temperature. 
2.1.6 Plasmids used in this study 
The transformed E. coli bearing the plasmid pYM43 containing the red fluorescent 
protein RedStar2 and the natNT2 cassette was purchased from EUROSCARF (Institute of 
Molecular Biosciences, Johann Wolfgang Goethe-University Frankfurt, Germany). This 
plasmid was created as part of the “PCR toolbox” (Janke, Magiera et al. 2004). 
The transformed E.coli bearing the plasmid pRS316 containing the URA3 selectable 
marker was kindly donated form D Bellows (School of Biological Sciences, Victoria 
University of Wellington). This plasmid was created as part of a series of yeast shuttle 
vectors allowing greater efficiency in the manipulation of DNA in Saccharomyces 
cerevisiae (Sikorski and Hieter 1989).  
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2.2 Methodology 
2.2.1 DNA preparation and manipulation 
2.2.1.1 Genomic DNA preparation 
Isolation and purification of Saccharomyces cerevisiae genomic DNA was achieved using 
the MasterPure Yeast DNA Purification Kit according to the manufacturers’ guidelines 
(Epicentre Biotechnologies, Madson, Wisconsin, USA). In brief, yeast cells were pelleted 
from saturated 1.5 mL cultures by centrifugation in a microcentrifuge tube at 10,000 rpm 
for 5 minutes. The pellet resuspended in 300 μL of Yeast Cell Lysis Solution by vortexing 
before samples incubated at 65 °C for 15 minutes. Samples were then placed on ice for 5 
minutes before addition of 150 μL of MPC Protein Precipitation Reagent and vortexed for 
10 seconds. The cellular debris were pelleted by centrifugation for 10 minutes at >10,000 
rpm and the supernatant transferred to a clean microcentrifuge tube. Genomic DNA was 
then precipitated by isopropanol precipitation (section 2.2.1.4) and subsequent ethanol 
precipitation (section 2.2.1.3) and then suspended in 35 μL of Tris EDTA (TE) buffer.  
In order to degrade any RNA present the purified DNA was then treated with 5 μg of 
RNase A and incubated at 37 °C for 30 minutes. The RNase A was then removed with 
phenol:chloroform (section 2.2.1.2) followed by ethanol and isopropranol precipitations 
(method 2.2.1.3 and 2.2.1.4) The size of the DNA was assessed by DNA electrophoresis 
(method 2.2.1.5) and quality assessed by DNA quantification (method 2.2.1.6). 
2.2.1.2 Phenol Chloroform Isoamyl alcohol DNA extraction 
Phenol chloroform isoamyl alcohol DNA extraction was preformed according to standard 
methods (Ausubel 1988). An equal volume of phenol: chloroform: isoamyl alcohol 
(25:24:1) was added to the DNA sample and vortexed to mix before centrifugation at 
16,000 xg for 10 minutes. The aqueous layer was removed and added to an equal volume 
of chloroform, mixed by a brief vortex and centrifuged at 16,000 xg for 10 minutes. The 
aqueous layer was then removed and kept. 
2.2.1.3 Ethanol precipitation   
Ethanol precipitation was preformed according to standard methods (Ausubel 1988). 
Sample DNA was prepared by the addition of 2.5 volumes of 96% Ethanol and 1/10 
volume of 3 M sodium acetate (pH 5.3), mixed by gentle inversion and incubated at -20 °C 
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for 25 minutes. The sample was then centrifuged in a microcentrifuge for 10 minutes at 
16,000 xg collecting the pelleted DNA. The pellet was then washed with 1 volume of 70% 
ethanol, centrifuged at 16,000 xg for 5 minutes, the resulting pellet was then air dried in 
the fume hood for 15 minutes and resuspended in 35 μL of TE buffer. This was then 
incubated at 65 °C for 10 minutes to ensure the DNA had completely dissolved. 
2.2.1.4 Isopropanol precipitation  
Isopropanol precipitation was performed according to standard methods (Ausubel 1988). 
Briefly, ammonium acetate was added at a final acetate concentration of 2 M, followed 
by 0.7 volumes of isopropanol. After 15 minutes incubation at room temperature the 
precipitated DNA was recovered by micro-centrifugation and the pellet air-dried at room 
temperature for a further 15 minutes before being resuspended in TE buffer  
(1 mM EDTA, 10 mM Tris-HCl pH 7.5). 
2.2.1.5 Agarose gel electrophoresis 
Agarose gel electrophoresis was performed according to standard methods (Ausubel 
1988). Briefly, electrophoresis was performed in 1% agarose gels, run in Tris Borate EDTA 
(TBE) buffer (89 mM Boric Acid, 2 mM EDTA disodium dihydrate, 89 mM Tris Base pH 8.3) 
with 0.5 μg/ml ethidium bromide. All samples were dissolved in TE buffer and mixed 5:1 
with 6x sample loading buffer (30% glycerol (v/v), 0.25% (w/v) bromophenol blue, 0.25% 
(w/v) cyanol xylene) prior to loading onto the gel. The 1Kb plus DNA ladder, prepared for 
gel loading as above, was used as a DNA size control and was purchased from Invitrogen 
(Carlsbad, CA, USA). Electrophoresis was performed at a constant 100 V and visualized on 
a transilluminator at 365 nm (UVItec, Cambridge, UK). 
2.2.1.6 DNA quantification 
Quantification of DNA was performed with the Sigma DNA Quantification Kit, DNA-QF 
(Sigma-Aldrich) according to the manufacturers’ instructions. In brief, a 2 μg/mL solution 
of the fluorescent H33258 dye was prepared prior to use. In a microtitre plate, 200 μL of 
the dye solution was added to each of a series of DNA standards (calf thymus DNA), with 
known concentrations ranging from 20 - 2000 ng of DNA. A standard curve of H33258 dye 
fluorescence at known concentrations was generated by excitation at 360 nm and 
measuring fluorescence on a SpectraMax Plate reader at 460 nm. The resulting standard 
curve was used to measure the DNA quantity of 5 μL of DNA sample. 
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2.2.1.7 Plasmid purification and isolation 
Isolation and purification of plasmid DNA from DH5α E. coli was performed with the 
Zyppy Plamid Miniprep Kit (Zymo Research Corporation, Irvine, CA, USA) according to the 
manufacturers’ instructions. In brief, 600 μL of a bacterial culture grown in LB medium 
was added to a 1.5 mL microcentrifuge tube before addition of 100 μL of 7x Lysis buffer. 
The solution was then mixed by inversion and within two minutes 350 μL of cold 
neutralization buffer was added and thoroughly mixed to ensure complete neutralization. 
The solution was then pelleted by centrifugation at 16,000 xg for 4 minutes before the 
supernatant was transferred into the provided Zymo-Spin II column. The column was 
then placed in a collection tube, centrifuged for 15 seconds and the flow through 
discarded. The column was then placed back in the collection tube and 200 μL of Endo-
wash buffer was added before the column was centrifuged for a further 15 seconds. 400 
μL of Zyppy wash buffer was added to the column before centrifugation for 30 seconds 
and transfer of the column into a clean 1.5 mL microcentrifuge tube.  Zyppy elution 
buffer, 30 μL, was added directly to the column matrix and left to stand at room 
temperature for one minute before the plasmid DNA was eluted via 15 s of 
centrifugation. The plasmid DNA was then kept at 4 °C until required for further 
experiments. 
2.2.1.8 Restriction digest of plasmid 
The purified plasmid pRS316 was subjected to restriction digest by the restriction 
endonucleases XbaI and HindIII (New England Biolabs, Ipswich, MA, USA) by a modified 
version of the digestion protocol from New England Biolabs (New England Biolabs, 
Ipswich, MA, USA). In brief, 42.5 μL of pRS316 suspended in LB media was added to a 1.5 
mL microcentrifuge tube. To this, 5 μL of 10x NEBuffer #2, 0.5 μL of BSA and 1 μL of both 
XbaI and HindIII were added, all of which were purchased from New England Biolabs  
(New England Biolabs, Ipswich, MA, USA). The solution was then thoroughly mixed and 
incubated at 37 °C for 12 hours to ensure complete digestion.  
2.2.1.9 Post digestion plasmid clean up 
The endonuclease enzymes utilised in the restriction digest protocol were denatured and 
removed along with any other contamination in order for future use of digested pRS316. 
This was performed with the PCR clean-up protocol which is a part of the Gel/PCR DNA 
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fragments extraction kit (Geneaid Biotech Ltd, Agoura Hills, CA, USA). In brief, 48 μL of 
the digest reaction product was transferred to a 1.5 mL microcentrifuge tube along with 5 
volumes of DF buffer and the two were mixed thoroughly. This solution was transferred 
to a DF column in a 2 mL collection tube and centrifuged at 16,000 xg for 30 seconds. 
After the flow through was discarded, 600 μL of Wash Buffer (ethanol added) was added 
to the centre of the DF column and left to stand for 1 minute. The column was then 
centrifuged at 16,000 xg for 30 seconds, flow through discarded and then centrifuged for 
a further 3 minutes at 16,000 xg in order to dry the column matrix. The dried DF column 
was then transferred into a new 1.5 mL microcentrifuge tube and 50 μL of elution buffer 
was added into the centre of the column matrix. This was allowed to stand at room 
temperature for 2 minutes to ensure the elution buffer was completely absorbed before 
a final centrifugation for 2 minutes at 16, 000 xg to elute the purified DNA. The purified 
DNA was then stored at 4 °C until required for future use.  
2.2.1.10 Polymerase Chain Reaction (PCR) 
The TIF1-RFP component module construction PCR was performed using the Qiagen 
Hotstar Taq DNA polymerase Kit with the following PCR reaction conditions (Bio-Strategy 
Ltd, Auckland, New Zealand).  
Component module construction PCR was performed using the Techne TC-5000 thermal 
cycler (Bibby Scientific, Staffordshire, UK) at the optimised cycling conditions: 15 min 
initial denaturation at 95 °C, then 10 cycles of 1 min at 97 °C (denaturation), 30 sec at  
54 °C (annealing), 2 min 40 sec at 68 °C (elongation). Followed by a further 20 cycles of 1 
min at 97 °C (denaturation), 30 sec at 54 °C (annealing), 2 min 40 sec at 68 °C, for the first 
cycle and incrementally increasing by 18 s per cycle thereafter until the final cycle of 8 
min 40 s at 68 °C (elongation). Following this was a final elongation for 5 min at 72 °C. The 
resulting PCR product (1 μL) was subjected to DNA electrophoresis and DNA 
quantification as described in sections 2.2.1.5 and 2.2.1.6 respectively. 
 
 
 
25 
 
Reagent Volume (μL) 
10X buffer  (15 mM MgCl2) 5 
Q buffer 10 
dNTP (5 mM) 2 
MgCl2 (25 mM) 0.28 
ddH2O 29.47 
Hotstar Taq (5 units/μ l) 0.5 
Fwd Primer (100 pM) 0.5 
Rev Primer (100 pM) 0.25 
DNA Template 2 
Total 50 
Table 2.1: Reaction setup for the component module construction PCR using Qiagen 
Hotstar Taq DNA polymerase. 
 
The primers used in the component module construction PCR, described in Table 2.2, 
were ordered from Integrated DNA technologies (IDT, Leuven, Belgium) and suspended in 
water to a final concentration of 100 pM. 
Table 2.2: Primers used in the TIF1-RFP component module construction PCR, their 
laboratory identification number, sequence, and acknowledgement of which primer sets 
match to make all component modules. 
Identification 
Number 
Primer Sequence 
#484 Module 1 
Forward 
CAGTCACGACGTTGTAAAACGACGGCCAGTGAATTGTAATTC
AGCAACAACATCCGATGCTT 
#485 Module 1 
Reverse 
ACCTGCACCAGCTCCAGCTCCGTTCAACAAAGTAGCGATGTCG
GATGGCAATTCTTCAATTT 
#486 Module 2 
Forward 
AATTGAAGAATTGCCATCCGACATCGCTACTTTGTTGAACGGA
GCTGGAGCTGGTGCAGG 
#378 Module 2 
Reverse 
TAGCCTCACAAGATACTTTTTTAAGAAGTTTTTGTCTCCCTTAC
AAGAACAAGTGGTGTC 
#487 Module 3 
Forward 
ACTGAAGGTAGACACCACTTGTTCTTGTAAGGGAGACAAAAA
CTTCTTAAAAAAGTATCTTGTGAGGCTATCTTG 
#488 Module 3 
Reverse A 
CGGCTCCTATGTTGTGTGGAATTGTGAGCGGATAACAATTTTT
GATGTACACTTTTTCTTTTCAG 
#489 Module 3 
Reverse B 
CGGCTCCTATGTTGTGTGGAATTGTGAGCGGATAACAATTTTT
GATGTACACTTTTTCTTTT 
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2.2.2 Dual fluorescent strain generation 
2.2.2.1 Transformation 
Transformation of S. cerevisiae was performed using a modified version of the lithium 
acetate/ single stranded carrier DNA/ PEG method (Gietz and Schiestl 2007). A single 
colony of each strain to be transformed (see section 2.1.3) was inoculated into YPD media 
and incubated overnight at 30 °C with constant agitation. The following day the culture 
was diluted to an OD600 of 0.05 in YPD and returned to incubate at 30 °C until OD600 
reading reached 0.7-1.2. The cell density was then measured using a haemocytometer 
and the volume corresponding to 1 x 108 cells were removed. The cells were then 
pelleted by centrifugation at 4000 rpm and washed three times with distilled water. The 
procedure was then continued in one of two ways depending on how many plasmids 
were included in the transformation. 
A) For single plasmid transformations  
Cells were the resuspended in transformation mix (33.33% PEG 3350 (w/v), 0.27 mg/mL 
single stranded salmon sperm DNA, 0.1 M lithium acetate) containing 1 μg of the plasmid 
DNA and incubated at 42 °C for 40 min.  
B) For multiple plasmid transformation 
Cells were the resuspended in transformation mix (33.33% PEG 3350 (w/v), 0.27 mg/mL 
single stranded salmon sperm DNA, 0.1 M lithium acetate) containing 1 μg each of all the 
plasmid DNA to be transformed. For example the dual fluorescent strain required the 
addition of 1 μg of each pRS316, and the aforementioned Modules 1-3. This solution was 
then incubated at 42 °C for 40 min. 
Subsequent steps of both transformation procedures were carried out identically. 
Samples were centrifuged for 1 min and the supernatant discarded. The remaining pellet 
was resuspended in 1 mL of YPD and left to incubate at 30 °C for 1 hour. Following the 
sample was centrifuged for 1 min, supernatant discarded and pellet washed in 1 mL YPD. 
Onto an agar plate, of appropriate selection media, 150 μL of the solution was added. 
This was evenly distributed across the plate by a glass rod, sterilized by an ethanol soak 
passed through the flame of a Bunsen burner. The remaining sample was then 
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concentrated by pelleting the sample by centrifugation for 1 min and resuspending the 
sample in 200 μL of YPD. Using the same procedure as above, 150 μL of the concentrated 
solution was streaked onto a second agar plate of the same selection media. Both plates  
were then incubated at 30 °C for 3-4 days to allow for transformant growth. 
As the presence of both fluorescent proteins used in this study cannot be attained 
through positive selection markers (RFP does not have a selection marker attached), the 
presence of the fluorescent proteins were confirmed through confocal microscopy 
utilising the OPERA microscope. A sample of the transformant, diluted in the appropriate 
selection media, was viewed under the OPERA microscope to detect for the presence and 
correct sub-cellular localisation of both fluorescent proteins.  
Transformant samples which met this requirement were restreaked on the appropriate 
selection media, allowed to grow, then selected and frozen down in 25% glycerol stocks. 
2.2.3 LOPAC library HTS of dual fluorescent probe 
Liquid handling of the LOPAC library was performed using a CyBi-Well 96-channel 
simultaneous pipettor (CyBio AG, Jena, Germany) in order to generate a 384-well library 
available for high throughput screening (HTS). To each plate in the library, 1  µL of each 
compound (using 1 µL pins) from the 96-well format was transferred into 49 µL, of the 
appropriate growth media in a 384-well clear bottom plate (PerkinElmer CellCarrier).  As 
multiple strains were being treated during each HTS screen and these fluorescent strains 
have differing growth requirements both the LOPAC library and the strains being 
screened were prepared differently. The strictly GFP strains were screened in media 
containing LOPAC compound and 49 μL of SC – His media whilst the dual fluorescent 
strain were screened in media containing LOPAC compound and 49 μL  of SC – (His, Ura). 
The pins were subjected to subsequent methanol (Scharlau Chemie, S.A)/DMSO rinses 
and blotting on fresh filter paper between plates in order to keep the pins clean and stop 
contamination. The libraries 16 plates were arrayed four times into a corresponding 384 
well plate. Thus, generating a set of 16 384-well plates, where each compound of the 
LOPAC library was represented in the corresponding plate in quadruplicate (4 µL of each 
compound total).  
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2.2.3.1 Growth Conditions and Image preparation 
Following the preparations described above, the single TIF1p-GFP and TIF2p-GFP strains 
were then manually added to each alternating well in the top row of the first 384-well 
clear bottom plate before the dual fluorescent constructs: TIF1p-GFP TIF1-RFP and TIF2p-
GFP TIF1-RFP were added in the same pattern to the second row of the same plate. This 
pattern was then continued ensuring that all LOPAC drugs were being exposed to all 4 
strains. An example of the plating pattern described above is illustrated in Figure 2.1. 
 
Figure 2.1: Illustration of LOPAC screen 384-well plate plan. Incorporation of four 
different fluorescent yeast strains with differing selection requirements into one 
screening plate. Starting at Row A, every other row contains SC - His media whilst starting 
at Row B every other row contains SC – (His, Ura) media. The pattern, continued 
throughout the entire plate, is colour coordinated to the fluorescent protein (or proteins) 
which were manual pinned in the corresponding well.  
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The plate was then left to settle for 10 min before image acquisition by confocal 
microscopy (see section 2.2.3.2). The plate was then shaken at 1000 rpm for 1 min and 
placed in a 30 °C incubator before a further image was acquired after 4 h. This process 
was then repeated for all remaining 384 clear bottom plates inoculated with the LOPAC 
library. 
2.2.3.2 Image Acquisition 
Each plate was imaged initially and after 4 h using OPERA, an automated spinning disc 
confocal microscope with a 60x water emersion lens. Using an exposure time of 200 ms, 
GFP was excited with a 488 nm laser. The emitted light was separated through a 568 nm 
primary dichroic mirror and filtered through 520/35 nm bandpass filter for imaging of 
GFP.  
For the two dual fluorescent strains both GFP and RFP imaging was required. The GFP 
image was captured as above and the RFP was captured separately, directly after the GFP 
image was captured, in an attempt to limit the effects of fluorescent cross over between 
the channels. Using an exposure time of 200 ms, RFP was excited with a 561 nm laser. 
The emitted light was separated through a 568 nm primary dichroic mirror and filter 
through a 600/40 nm bandpass filter for imaging of RFP.  
In either case for each field of view, three z-stacks were imaged each 1 µm apart covering 
different depths of the cell. Each plate took approximately 20 mins to image.  
2.2.3.3 Image Analysis 
Images were analysed using the image recognition software Acapella, which utilises 
fluorescent markers to identify and segment individual cells. The images generated by 
Acapella were analysed using a modified version of the methodologies established in our 
laboratory (Bircham, Maass et al. 2011).  
The image recognition process developed by Bircham et al., (2011) analyses yeast strains 
with a GFP fused to a gene of interest as well as a nuclear localisation signal (NLS) protein 
fused with the marker Redstar2 (NLS-RedStar2)  and an mCherry cytoplasmic marker. The 
bright NLS marker was used to locate and identify the nucleus by thresholding and water 
shedding techniques before whole cells were identified in the same way by the fainter 
mCherry cytoplasmic marker. Reporter strains used in the current research however lack 
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these markers so cell objects were identified without the nuclei identification and whole 
cells were identified by cytoplasmic TIF-GFP.  
In brief, the script adapted from Bircham et al., (2011), employs cytoplasmic TIF-GFP to 
find all potential cells contained in each well and using thresholding and water shedding 
techniques defines accurate cell boundaries. Upon accurate cell boundary identification, 
of the three z-stacks imaged (see section 2.2.3.2), only the z-stack which represents the 
cell midsection were analysed. The GFP and or RFP intensity were then calculated based 
on the average pixel intensity within the cell objects boundaries. The fluorescence 
intensities were then reported for every single cell identified in the well not just an 
average of the entire wells’ fluorescence intensity.  
2.2.3.4 Statistical analysis of LOPAC screen  
Sample whole cell fluorescence intensities were compared against that of control whole 
cell fluorescence intensities using the Wilcoxon rank sum test (Wilcoxon 1945) as 
implemented in the freely available software program R (R version 2.12.2 The R 
foundation for statistical computing). The p values generated by the Wilcoxon rank sum 
text were then subjected to the Bonferroni correction for multiple comparisons (Dunnett 
1955), generating Q values, as implemented in the program R.  
Each compound was then presented as a ratio of sample whole cell fluorescence 
intensities over control whole cell fluorescence intensities. The compounds were, using 
this ratio, ranked from greatest observed increase in GFP expression to greatest observed 
decrease in GFP expression.  This list was then refined to only include compounds that 
had an associated Q value of <0.01, such compounds were considered hits.  
Where appropriate the GFP and RFP components for each strain were treated as though 
each were a completely different screen, hence a list of hits for both GFP and RFP 
components for the dual fluorescent strains were generated. 
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3 Results and Discussion 
3.1 Creation of a TIF1p-RFP fusion protein 
In order to dissect eIF4A’s role as a part of the yeast translational machinery, the genes 
TIF1 and TIF2 were evaluated.  As previously stated, the potential for genetic redundancy 
amongst duplicate genes hampers the efficiency of many standard research techniques, 
and subsequently to circumvent this issue a fluorescent based methodology was 
adopted.  The ultimate goal of this research is to generate a set of fluorescent reporter 
strains integrated into the genome via the chromosome instead of being dependent on 
exogenous plasmids. However, the plasmid borne system was an achievable intermediate 
goal suitable for a Masters project. In addition this system, if successfully generated, still 
could be used to evaluate whether TIF1 and TIF2 can be individually regulated by small 
molecule intervention. Thus, construction of the reporter strains with a plasmid based 
TIF1p-RFP was pursued. 
3.1.1 Primer design and module creation 
To create the reporter strain TIF1p-RFP TIF2p-GFP a TIF1p-RFP fusion protein needed to 
be composed and united with the TIF2p-GFP strain from the commercially available Yeast 
GFP Clone Collection. To generate the TIF1p-RFP fusion, polymerase chain reaction  
(PCR) – mediated module construction was employed to produce analogues of the major 
constituents required for a TIF1p-RFP fusion, namely; a TIF1 Open Reading Frame (ORF) 
with endogenous promoter (TIF1pr) and endogenous terminator region (TIF1tr), a source 
of RFP as well as the shuttle vector pRS316. Furthermore, these modules had to include 
additional flanking regions with significant overlap between modules allowing for their 
union through homologous recombination. These flanking regions were incorporated into 
each module through the use of primers with sticky ends to the DNA source each primer 
would amplify. The primer design and resulting module constructs are outlined in Figure 
3.1 and Table 3.1 respectively. 
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Figure 3.1: Primer design employed when creating TIF1-RFP via PCR mediated module 
construction. At the top is the full length construct produced whilst aligned below are the 
primers, with associated catalogue number, that were used. Flanking regions were 
incorporated in the modules through the use of primers with sticky ends to the source of 
DNA which the primer would amplify. The figure is colour coded to show each DNA 
source of the major constituents; TIF1 ORF, TIF1pr and TIF1tr = black, CEN plasmid 
pRS316 = green, and RFP = red. The primers use this same colour code to show the sticky 
end parts of each primer.  
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Table 3.1: The construct design of the TIF1p-RFP modules as assembled through PCR 
mediated module construction. The size (in base pairs) of each module, and the primer 
sets required to generate them. In modules where a fraction of a component is present 
an arrow head is shown as opposed to a full block illustrating a complete component.  
 
In order to limit the ambiguity with which the modules were allowed to form, specific 
strains and plasmids were utilised in their construction. In addition to the primer sets 
described, module 1 required a source of genomic TIF1 for successful amplification. 
Therefore tif2Δ::KANMX4, his3Δ1, leu2Δ0, met15Δ0 and ura3Δ0 from the yeast knockout 
MATa strain collection was selected in an endeavour to limit any possibility of TIF2 
supplanting TIF1 and fusing to the RFP in its place. As module 3 also required a source of 
genomic TIF1 present to amplify the endogenous TIF1 terminator (TIF1tr) the 
aforementioned strain was again utilised. RedStar2, the RFP source that module 2 utilised 
for amplification, was sourced from the plasmid pYM43.  
Following PCR-mediated component module construction (see methods 2.2.1.10) each 
module was confirmed electrophoretically as shown in Figure 3.2. That bands 
corresponding to each module were determined by comparing the DNA markers and 
unknown bands with the expected module sizes, as reported in Table 3.1.  
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During the primer design phase of this research, two different reverse primers for module 
3 were devised (See Table 2.2). The two were created with varying lengths of sequence 
homology to the TIF1 terminator, an area that had potential to hinder the success of any 
subsequent PCR, promoting the success of a specific step in the creation of TIF1p-RFP. 
The longer “reverse primer A” endowed greater provision for the success of homologous 
recombination whilst the shorter “reverse primer B” was expected to be better equipped 
for the PCR phase of TIF1p-RFP construction. However, since both primers resulted in 
successful amplification of module 3, the module constructed with reverse primer A was 
applied in the subsequent steps of TIF1p-RFP construction. 
 
Figure 3.2: PCR mediated component module construction. Lanes: 1 – Module #1,  
2- Module #2, 3- 1:10 dilution of Module #2, 4- Module #3 using primer #488 as reverse 
primer, 5- Module #3 using primer #489 as reverse primer, 6- Negative PCR control,   
L - 1Kb plus DNA ladder. The coloured stars represent the versions of each module which 
were utilised in subsequent experiments. 
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3.1.2 Introduction of modules into a functional host 
In order for yeast strains to integrate and express  the desired TIF1p-RFP, these modules 
need to be integrated into a suitable vector which will be expressed inside the parental 
yeast strain alongside normal gene expression.  As previously stated, the use of sticky 
ended primers created regions of sequence overlap between the three modules granting 
the potential for homologous recombination to link the module into one linear segment. 
In addition this methodology facilitated the incorporation of the modules into the CEN 
plasmid pRS316 (Figure 3.3). 
 
Figure 3.3: Sites of sequence homology between modules and plasmid. These sites 
allow the facilitation of homologous recombination between each component of the 
TIF1-RFP construct. In modules where a fraction of a component is present an arrow head 
is observed as opposed to a full block illustrating a complete component.  
Colour key – green = Cen plasmid, black = TIF1 (ORF, TIF1pr and TIF1tr), red = RFP,  
black dash = sequence homology allowing homologous recombination. 
 
The incorporation of the TIF1-RFP construct into a circular plasmid would not naturally 
occur hence the plasmid must first be made linear. As pRS316 is selected for under the 
same selection pressure whether or not the TIF1-RFP construct is successfully 
incorporated in the plasmid it is necessary that the religation of a construct free pRS316 
be extremely unfavourable. Therefore, a 42 bp cut in the multiple cloning site of pRS316 
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was generated using the restriction enzymes XbaI and HindIII. This allowed for the 
incorporation of each module in pRS316 rather than the religation of a construct free 
pRS316.  
3.2 Construction of a dual fluorescent reporter strain 
To facilitate the homologous recombination and introduction of the TIF1-RFP modules 
into a functional strain of yeast, the transformation procedure described in section 
2.2.2.1 was performed (Figure 3.4). This process could have been achieved by many 
different methods, however transformation was preferred. The parental yeast strain, 
under standard transformation conditions, is able to facilitate homologous recombination 
and replication of the plasmid, as well driving transcription and translation of both 
plasmid borne and chromosomal gene copies. Thus no other external steps are required 
to create a functional fluorescent protein that will be expressed under normal cellular 
conditions. 
 
Figure 3.4: Plasmid borne TIF1-RFP. The CEN plasmid pRS316 with the TIF1-RFP construct 
inserted via transformation mediated homologous recombination. In order to make the 
TIF1-RFP respond in a manner as close to unlabelled TIF1 as possible, effort was made to 
incorporate both the endogenous promoter and terminator regions of TIF1 at the 5’ and 
3’ ends of the construct respectively. The selection marker for plasmid pRS316, URA3 is 
also shown.  
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In order to attain a one to one ratio between the number of copies of TIF1-RFP that were 
expressed in each cell, and hence a way of measuring cellular levels of TIF1, the shuttle 
vector pRS316 was selected in this study. The main advantage of shuttle vectors are their 
ability to propagate in two different host species  for example, pRS316 contains 
components that allow for the replication and selection in both S. cerevisiae and E.coli. 
This shuttle vector is one of a series of CEN-based plasmid (CEN plasmid) which are 
characterised by the presence of a centromere sequence as well as a normal yeast origin 
of replication. The CEN sequence is recognised by the host strains which are able to 
replicate the plasmid as though it was a small chromosome at a rate of one copy per cell. 
Of this plasmid set, pRS316 was utilised as it has a strong selection marker, URA3, which 
importantly is not being utilised as a selection marker for any other method employed 
during this research. 
Two parental strains were utilised during the transformation procedure to produce 
differing fluorescent reporter genes of interest. The most pertinent reporter gene to this 
study was TIF1p-RFP TIF2p-GFP which during this transformation step was created in the 
parental strain TIF2-GFP from the Yeast GFP clone collection (section 2.1.3).  
It is also important to note that satisfactory transmission of plasmid between parental 
and daughter generations was observed when allowed to grow on fresh media for five 
generations. However, the plasmid fluorescence intensity was more variable than the 
chromosomally expressed GFP. Confocal microscopy Images of the four strains utilised 
during LOPAC library screening are shown in Figure 3.5.  
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Figure 3.5: Confocal microscopy images of the 4 strains utilised in the HTS of the LOPAC 
library. Top Left – TIF1p-GFP, top right – TIF2p-GFP, bottom left – TIF1p-RFP TIF1p-GFP 
TIF2, bottom right – TIF1p-RFP TIF1 TIF2p-GFP. Images were converted from 16 bit to 8 
bit copies and therefore the brightness/expression levels cannot be used as direct 
comparisons between the four strains.  
 
Although these images cannot be directly used to correlate the brightness of each 
fluorescence protein to the gene expression levels in each strain (see caption above), it is 
important to note that the differences illustrated in these images reflect the underlying 
optical data and are not an artefact arising from either the image acquisition or image 
processing phases.  
Figure 3.5 clearly illustrates that the RFP signal from TIF1-RFP is weaker than that 
observed for the GFP equivalent. This is found consistently and does not arise from 
inherent fluorescence efficiencies of the red and green fluorescent proteins. Literature 
records that S65T GFP has an extinction coefficient of 65,000 M-1cm-1 and a quantum 
yield of 64% (Patterson, Knobel et al. 1997). RedStar2 has been shown to have an 
intensity 2-4 times greater than that of DsRed, coupled with a lower tendency to 
aggregate (Janke, Magiera et al. 2004). DsRed has an extinction coefficient of 
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approximately 75,000 M-1cm-1 and a quantum yield of approximately 0.75 (Heikal, Hess et 
al. 2000). This shows that the RFP RedStar2 should be at least as bright as the S65T GFP.  
In addition to the overall brightness levels of the two fluorescent proteins , these images 
highlight three trends observed throughout the dataset. Firstly that, in the case of GFP, 
the GFP expressed is more intense before the introduction of the second fluorescence 
source. Secondly, the chromosomally expressed GFP is more intense than their plasmid 
RFP counterparts.  Finally, that the RFP present in both the dual fluorescent strains, even 
though fused to the same protein, is being expressed in two unsimilar ways. The RFP 
signal generated from TIF1p-RFP TIF1p-GFP is evenly expressed in the cytoplasm, whilst 
the RFP signal generated from TIF1p-RFP TIF2p-GFP, is expressed in a more punctate 
pattern throughout the cytoplasm.   
A possible explanation for the first and second trends may arise from the approach with 
which the two dual fluorescent strains were generated. At the beginning of this research 
there was no established precedent that suggested it was possible to individually identify 
both TIF1 and TIF2 in the single environment. Therefore it was expedient in this initial 
study to work with the untransformed commercial TIF2-GFP strain. Consequently a third 
source of the eIF4A protein was retained in both the dual fluorescent strains resulting in 
the genotypes TIF1-RFP TIF1-GFP TIF2 and TIF1-RFP TIF1 TIF2-GFP (herein these strains 
will be referred to without the third TIF gene unless required). As such, the low apparent 
signal of TIF1-RFP as well as the higher signal intensity of the GFP in the single fluorescent 
strains as opposed to the dual strains maybe, to some extent, a consequence of the 
cellular demand for eIF4A being supplied by a greater number of genes that can only 
compete for a limited number of transcription factors .  
With regard specifically to the low apparent signal of TIF1-RFP, the second highlighted 
trend, the explanation may also lie in the UTR and location of the gene. It is plausible that 
some transcription factor associations are lost or otherwise affected in a way unique to a 
plasmid based expression system. Such potential differences between the genomic 
architecture of chromosomal and plasmid borne expression systems are a largely 
unknown quantity at play in this intermediary CEN plasmid construct.    
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In regard to the third trend, it is possible that the punctate RFP pattern, observed only in 
TIF1p-RFP TIF2p-GFP, was caused by a number of factors unique to the genetic 
interaction of the plasmid borne TIF1-RFP with the parental host strain. For example, it 
might be that there is a previously unrecognised mRNA localisation motif in the region of 
the 3’ UTR that has not been captured in this CEN plasmid construct. This could 
potentially cause misslocalisation of TIF1 and a loss of function. However, normal 
function would be retained regardless as a consequence of the third unlabelled source of 
eIF4A. Alternatively, TIF1p-RFP may be more accurately reflecting the impact that the 3’ 
UTR  is having on site directed localisation than TIF1p-GFP, since the commercially 
available strains have their 3’ UTR disrupted by various selection markers.  
It is also possible this pattern is, to some extent, caused by the combination of three 
eIF4A genes contributing to cellular demand. The combination of three genes increases 
the maximum potential eIF4A that can be synthesised which may lead to an increased 
total abundance of eIF4A. The result of this rise in total abundance may force an increase 
in the aggregation of either eIF4A or the RFP. Additionally the punctate pattern may be 
caused by differences in the nature of the third eIF4A source in each of the dual 
fluorescent reporter strains.  As the RFP is located on TIF1, the retention of a second 
unlabelled copy of TIF1, as is found in TIF1p-RFP TIF1 TIF2p-GFP, could result in either the 
unlabelled TIF1 being produced in favour of TIF1-RFP or an overabundance of TIF1 in 
general.  
If the punctuate pattern observed were a consequence of any of these suggestions then 
performing a dye swap experiment, where the fluorescent proteins assigned to each gene 
of the dual fluorescent reporters were swapped, would illustrate this by causing the RFP 
expression patterns observed for each dual fluorescent reporter to alternate.   
Despite the aforementioned limitations it was anticipated that the TIF1-RFP would still 
effectively report on treatments that lead to changes in TIF1 expression.  Thus, these 
strains were still utilised to a) identify whether the abundance differences of TIf1p and 
Tif2p can be detected in this system and b) to evaluate the possible screening 
methodologies for future use. An overview of the methodologies utilised to create the 
TIF1p-RFP TIF2p-GFP reporter are shown in Figure 3.6. 
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Figure 3.6: Overview of TIF1p-RFP TIF2p-GFP strain generation.  All components of the 
three TIF1-RFP modules were individually isolated by either genomic or plasmid DNA 
isolation. Components were then crafted into three TIF1-RFP modules via PCR mediated 
module construction utilising the noted primer scheme. The transformation process 
produced functionally active TIF1-RFP integrated, inside processed pRS316, in the 
parental host strain bearing the commercially available TIF2-GFP. 
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3.2.1 Application of dual fluorescent reporter strain 
A major advantage of the dual fluorescent reporter strain is its ability to be applied to a 
multitude of different methodologies. Throughout this study this strain had been 
employed in applications that utilise their fluorescent properties, however, as this 
reporter strain is essentially a collection of two epitope tags its use is not limited to 
applications with fluorescent based systems.  
The inspiration for the design of this study was driven by the work outlined in Deluna et 
al., (2010) who used fluorescent markers to investigate the regulation of protein levels, 
by duplicate genes in the S. cerevisiae genome, in response to the deletion of one their 
paralogous genes. In brief, the Deluna system utilised a pair of haploid yeast strains that 
were constructed with a duplicate gene fused to GFP in either the wild type background 
or in a background deleted for its paralog. In order to individually identify each strain 
they constitutively expressed either CFP or RFP respectively. Deluna was then able to 
coculture both strains, dose with the drug/drugs of choice and using three colour flow 
cytometry was able to measure the protein regulation by each duplicate gene in both 
wild type and deletion backgrounds (DeLuna, Springer et al. 2010). However, the TIF 
genes were not investigated during the aforementioned study to avoid complications of 
ribosomal protein genes and aneuploidy. 
As a consequence, this study was originally focused on creating a dual fluorescent strain 
that could be examined by flow cytometry to evaluate whether TIF1 and TIF2 can be 
individually regulated by small molecule intervention. However despite months of 
optimisation, it became increasingly clear that the HTS approach employed in this study 
was not conducive to the detection of small differences in protein regulation. Under the 
HTS conditions used, cells were growing in log phase. Under these circumstances, 
unrestricted cell cycle progression creates a high demand for protein synthesis, and it is 
likely that eIF4A usage was near maximal. For that reason, compounds that would elicit 
and increase in eIF4A would have been unlikely to create notable change in fluorescence, 
although suppressors of eIF4A should still have been apparent. Compounding this, the 
HTS system seemed to suffer from large noise in the observed fluorescence intensities, 
and this noise would mask small changes in the signal resulting from compound 
treatment. 
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Research, utilising the growth conditions outlined in section 2.2.3.1, investigating the 
effects of 35 µM atorvastatin on PDR5-GFP was conducted in tandem with this study. 
Atorvastatin, at this concentration, is known to up regulate PDR5, however this up 
regulation could not be detected via flow cytometry but was detectable by confocal 
microscopy (Ploi Yibmantasiri, Victoria University of Wellington, personal 
communication). As a goal of this research was to conduct high throughput 
methodologies the remaining experimentation was conducted using confocal microscopy 
in favour of flow cytometry. 
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3.3 Screening of the LOPAC1280 library  
Using the functional reporter strain TIF1p-RFP TIF2p-GFP, with distinguishable TIF1 and 
TIF2 markers, differentiation of the respective gene functions of TIF1 and TIF2 can be 
elucidated under a variety of cellular conditions. To encompass as many different 
variables as possible this strain was subjected to a morphological high throughput screen 
(HTS) utilising the LOPAC1280 Library of Pharmacologically-Active Compounds. This library 
was chosen as a library of environmental variables rather than as a library of bio-actives 
of interest. 
As indicated in section 2.2.3.2, readings from the LOPAC library HTS screens were taken 
at time zero and after a four hour incubation period. This methodology was exercised in 
an attempt to enrich the list of “hits” to only include compounds eliciting a response 
resulting from gene regulation.  As the initial time point for imaging is almost 
instantaneously after the introduction of the LOPAC library it is not conceivable that any 
observed changes in protein expression were regulated via changes in mRNA expression. 
Instead, it is plausible that any such changes are instigated by disturbances in the GFP 
signal or arise from intrinsic fluorescence in the compound library and not as a 
consequence of gene expression changes in response to the introduction of the LOPAC 
library. Hence any “hits” observed at the initial time point are considered a crucial control 
in eliminating those compounds that are not pertinent to the primary aim of this study; 
elucidating differential regulation between TIF1 and TIF2. 
Two compounds were consistently identified within the top twenty compounds that lead 
to an apparent GFP increase at both time points of every screen; SB 216763 and SU 5416. 
Rapid increases in fluorescence intensity, although not always to a level of statistical 
significance, were observed for SB 216763 and SU 5416 in all the screens which 
incorporated GFP. Furthermore the fluorescence intensity was at its highest, 
approximately 100 times that of control (see Figure 5.3 and Figure 5.6) from data sets 
procured at time point zero. As previously discussed, such rapid increases are unlikely to 
be a result of gene regulation but rather a result of intrinsic compound fluorescence or 
compound promoting fluorescence from some other mechanism. A brief literature search 
highlighted that SB 216763 was itself fluorescent and subsequently omitted in the 
analysis of previously conducted work with fluorescent proteins (Bayliss, Bellavance et al. 
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2006). Contrastingly SU 5416, with a similarly sizeable increase in GFP expression levels, 
was not identified as intrinsically fluorescent (Nuutinen, Ropponen et al. 2009). However, 
the mechanism by which SU 5416 increases the fluorescence intensity will not be further 
pursed in this study.  
The results of the 4 hour readings are presented and discussed below whilst the time zero 
readings are presented in Appendix A and discussed where necessary. 
3.3.1 Rational of statistical analysis 
The Wilcoxon rank sum test and Bonferroni correction for multiple comparisons are 
standard statistical analysis for non-parametric data sets such as those generated by the 
LOPAC library screening. However, it was expedient in this initial study to identify “hits” 
at a more stringent threshold than normally required so as to assess the system’s 
capabilities for identify compounds that caused differential regulation between the 
paralogous TIF genes. The threshold employed had a cut-off point of Q value <0.01, in 
other words the threshold filtered hits to maintain a false discovery rate <1 %.  
In addition to a low false discovery rate it was also pertinent to filter results on the 
strength of their associated ratio of sample whole cell fluorescence intensities over 
control whole cell fluorescence intensities. This streamlined the focus of this study to 
concentrate on the success of the fluorescent based system to identify substantial 
regulation differences between TIF1 and TIF2 whilst limiting the effect of experimentally 
introduced noise. This was achieved by assigning an arbitrary threshold on the 
aforementioned ratio of above 1.2 and below 0.8. 
For each of the screens, graphical representations for the following are presented; A) the 
ratio of sample whole cell fluorescence intensities over control whole cell fluorescence 
intensities for the entire library, B) The top twenty compounds (if possible), with Q values 
<0.01, that elicited an increase in fluorescence intensity C) The top twenty compounds  
(if possible), with Q values <0.01, that elicited a decrease in fluorescence intensity. 
The compounds highlighted in B) and C) were tabulated and presented with their 
associated ratio of sample whole cell fluorescence intensities over control whole cell 
fluorescence intensities and levels of statistical significance. 
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3.3.2 Single GFP screening – Reading at 4 Hours 
The central dogma of gene expression proposes that a single gene encodes for a single 
protein, however, duplicate gene pairs are able to encode for the same protein. Thus, 
from an experimental vantage point, it is possible to generate an impeded perception of 
a protein if not all of the protein manifestations are considered. Consequently, 
compounds which instigate differential regulation of the duplicate genes TIF1 and TIF2 
may draw varying conclusions if the genes were examined individually as opposed to  
co-examination. In contrast to the single GFP reporters, the dual fluorescent reporter is 
able to evaluate all manifestations of eIF4A in a single environment whilst acknowledging 
the role that both genes perform.  
Conversely the single GFP reporter screens are not redundant as they are used to validate 
both the dual fluorescent reporter as well as the choice of methodologies employed in 
deciphering the role of eIF4A as a part of yeast translation machinery. Screening these 
strains in conjunction with the dual fluorescent reporter allows suitable comparisons for 
the evaluation of the impact that genetic redundancy may have on TIF1 and TIF2.  
It is important to note that the set of singular GFP control screens applied to validate 
these methodologies, although necessary and appropriate in the ideal genomically 
integrated dual reporter system, are not a perfect validation of this system. As previously 
stated, an extra source of eIF4A was retained in the dual fluorescent reporter in the form 
of an unlabelled copy of TIF1 (see section 3.2). Subsequently not all manifestations of 
eIF4A are being monitored in a single environment. In addition the GFP set used as 
validation is integrated into the chromosome whilst the TIF1-RFP is a plasmid borne copy. 
Nevertheless although changes in TiF1 expression might be distributed between the two 
copies of TIF1 in these reporter strains it was anticipated that the TIF1-RFP would still 
effectively report on treatments that lead to changes in TIF1 expression.  
Although the primary objective of this project was to create a dual florescent reporter 
strain, the individual TIF1p-GFP and TIF2p-GFP strains were also screened to provide a 
point of reference. The commercially available Yeast GFP Clone Collection allowed high 
throughput screening of the LOPAC library against these singular GFP strains. The ensuing 
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screens are outlined in Figure 3.7/ Table 3.2 and Figure 3.8/Table 3.3 respectively and 
discussed below. 
3.3.2.1 TIF1p-GFP Screen 
Of the compounds screened against TIF1p-GFP 154 compounds, as ascertained by the 
Wilcoxon rank sum test (α = 0.01), elicited a significant increase in GFP expression when 
compared with control GFP. However, 83 compounds were unearthed in the same screen 
at the initial time point. Conversely, 155 compounds elicited a significant decrease in GFP 
expression when compared with control GFP with 48 compounds identified at the initial 
time point. Using an arbitrary established threshold of compound-treated GFP: control 
GFP ratio to constitute positive hits; above 1.2 and below 0.8, 3 compounds increased 
GFP expression whilst 19 decreased GFP expression. Although these thresholds are 
arbitrarily chosen, they reflect the aims of this study in identifying notable differentiation 
between the TIF genes. 
Three compounds; Myricetin, Mainserin hydrochloride and Orphenadrine hydrochloride 
were identified as decreasing GFP expression below a score of 0.8 in both the zero and 
four hour time points of this TIF1p-GFP screen. As already discussed any such changes are 
potentially instigated by disturbances in the GFP signal and not as a consequence of the 
introduction of the LOPAC library. It is possible that such instances of GFP signal 
interruption are consequences of compounds which instigate fluorescence masking or 
miss folding of the GFP protein or some other mechanism which modulates GFP directly. 
In the case of Myricetin, which has a highly conjugated structure, it seems plausible that 
this modulation be attributed to quenching of the GFP signal owing to a high extinction 
coefficient. A high extinction coefficient could lead to the absorption of light at one or 
both of the GFP excitation or emission wavelengths. 
Although identified as statistically significant by the Wilcoxon rank sum test (α = 0.01), 
these outliers are removed from detailed consideration here for reasons outlined in 
section 3.3. However, in future studies, they will be deserving of consideration. 
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Figure 3.7: Whole cell fluorescence intensities of TIF1p-GFP treated with the LOPAC library 
(compounds 1 – 1280) compared against the pooled collection of whole cell fluorescence 
intensities of TIF1p-GFP treated with DMSO (as described in section 2.2.3.4). (A) Compound-
treated GFP: control GFP for the entire LOPAC library ranging from highest to lowest. The top 20 
compounds that (B) elicited an increase in or (C) elicited a decrease in the ratio of  
compound-treated GFP compared to control. Compounds highlighted in B and C are presented in 
Table 3.2. 
49 
 
# Compound 
Compound GFP : 
Control GFP 
Q value 
 
Compound 
Compound GFP : 
Control GFP 
Q value 
1 SU 5416 * 1.922 6.47E-31   Myricetin * 0.469 5.315E-39 
2 4-Amino-1,8-
naphthalimide 
1.374 6.34E-30   Mianserin hydrochloride 
* 
0.4961 1.598E-31 
3 Alloxazine 1.201 0.008513   8-Cyclopentyl-1,3-
dimethylxanthine 
0.5426 1.834E-44 
4 Emodin 1.197 1.06E-07   DNQX 0.6196 9.033E-90 
5 S-Methyl-L-
thiocitrulline 
acetate 
1.163 5.85E-05   Muscimol hydrobromide 0.673 6.271E-80 
6 GW9662 1.149 1.76E-05   Orphenadrine 
hydrochloride * 
0.6982 1.663E-60 
7 (±)-Nipecotic 
acid 
1.145 0.005389   Histamine, R(-)-alpha-
methyl-, dihydrochloride 
0.72 4.963E-79 
8 1,1-Dimethyl-4-
phenyl-
piperazinium 
iodide 
1.133 4.09E-05   E-64 0.7235 1.345E-13 
9 Flumazenil 1.132 4.36E-21   Etodolac 0.7236 2.335E-17 
10 S-
Nitrosoglutathi
one 
1.119 6.14E-10   Phenoxybenzamine 
hydrochloride 
0.7352 8.048E-05 
11 (±)-2-Amino-7-
phosphonohep
tanoic acid 
1.119 4.56E-06   Dihydro-beta-
erythroidine 
hydrobromide 
0.7413 2.183E-17 
12 Quazinone 1.116 7.08E-15   1-(m-Chlorophenyl)-
biguanide hydrochloride 
0.7604 4.252E-43 
13 (±)-
Chlorphenirami
ne maleate 
1.112 0.000212   R(-)-2,10,11-Trihydroxy-N-
propylnoraporphine 
hydrobromide 
0.7703 1.451E-09 
14 Chelerythrine 
chloride 
1.111 2.83E-09   Doxazosin mesylate 0.7769 5.588E-10 
15 R(+)-3PPP 
hydrochloride 
1.111 1.8E-12   (+)-Butaclamol 
hydrochloride 
0.7843 7.77E-09 
16 AA-861 1.11 1.17E-05   T-1032 0.7898 3.692E-38 
17 erythro-9-(2-
Hydroxy-3-
nonyl)adenine 
hydrochloride 
1.107 1.31E-15   (±)-threo-1-Phenyl-2-
decanoylamino-3-
morpholino-1-propanol 
hydrochloride 
0.7908 6.033E-49 
18 NS 2028 1.105 4.2E-09   Phosphonoacetic acid 0.7972 4.414E-50 
19 Cefmetazole 
sodium 
1.105 3.41E-09   Dipropyldopamine 
hydrobromide 
0.7978 4.345E-08 
20 Ellipticine 1.104 0.000367   Emetine dihydrochloride 
hydrate 
0.8047 5.004E-08 
Table 3.2: The top 20 compounds that elicited an increase or a decrease in the observed ratio of 
compound-treated GFP compared to control GFP from the TIF1p-GFP screen (LHS and RHS 
respectively). Compounds were only deemed significant if their associated Q values were <0.01 
(Q value calculation as described in sections 2.2.3.4 and 3.3.1). Compounds marked with an 
asterisk denote those compounds which appear in both t=0 and t=4 hours.  
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3.3.2.2 TIF2p-GFP Screen 
Of the compounds screened against TIF2p-GFP 147 compounds, as ascertained by the 
Wilcoxon rank sum test (α = 0.01), elicited a significant increase in GFP expression when 
compared with control GFP. However, 27 compounds were unearthed in the same screen 
at the initial time point. Conversely, 125 compounds elicited a significant decrease in GFP 
expression when compared with control GFP with 23 compounds identified at the initial 
time point.  
Using an arbitrarily chosen threshold of compound-treated GFP: control GFP ratio to 
constitute positive hits; above 1.2 and below 0.8, 4 compounds increased GFP expression 
whilst 36 decreased GFP expression. Of these 40 compounds only Ro 16-6491 
hydrochloride, shown to down regulate fluorescence intensity, was identified at both 
time points. Although identified as statistically significant by the Wilcoxon rank sum test 
(α = 0.01), Ro 16-6491 hydrochloride was removed from detailed consideration here  for 
the reasons outlined in section 3.3. However, in future studies, Ro 16-6491 hydrochloride 
will be deserving of consideration. 
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Figure 3.8: Whole cell fluorescence intensities of TIF2p-GFP treated with the LOPAC library 
(compounds 1 – 1280) compared against the pooled collection of whole cell fluorescence 
intensities of TIF2p-GFP treated with DMSO (as described in section 2.2.3.4). (A) Compound-
treated GFP: control GFP for the entire LOPAC library ranging from highest to lowest. The top 20 
compounds that (B) elicited an increase in or (C) elicited a decrease in the ratio of compound-
treated GFP compared to control. Compounds highlighted in B and C are presented in Table 3.3. 
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# Compound 
Compound GFP : 
Control GFP 
Q value 
 
Compound 
Compound GFP : 
Control GFP 
Q value 
1 AIDA 1.275 0.000193   8-Cyclopentyl-1,3-
dimethylxanthine 
0.4309 7.473E-27 
2 (-)Amethopterin 1.25 5.08E-06   N6-Benzyl-5'-N-
ethylcarboxamidoadenosin
e 
0.5824 0.00448 
3 Enoximone 1.232 9.3E-39   DD1 0.6153 0.0002132 
4 1-benzoyl-5-
methoxy-2-
methylindole-3-
acetic acid 
1.226 0.002597   5,7-Dichlorokynurenic acid 0.6839 1.865E-09 
5 Se-
(methyl)selenocyst
eine hydrochloride 
1.183 2.05E-05   Dipyridamole 0.6958 2.191E-09 
6 Adenosine amine 
congener 
1.17 0.00647   Muscimol hydrobromide 0.7033 7.403E-20 
7 (±)-Pindobind 1.149 2.78E-13   DBO-83 0.7111 3.882E-08 
8 alpha-Lobeline 
hydrochloride 
1.144 1.74E-08   DNQX 0.7111 1.504E-19 
9 Chelerythrine 
chloride 
1.144 9.02E-08   Ro 16-6491 hydrochloride * 0.7237 3.181E-39 
10 2-
Phenylaminoadeno
sine 
1.144 5.61E-11   6-Hydroxy-DL-DOPA 0.7282 2.029E-13 
11 Quinelorane 
dihydrochloride 
1.142 3.42E-12   Dihydro-beta-erythroidine 
hydrobromide 
0.7404 5.575E-10 
12 Isonipecotic acid 1.141 5.88E-07   N,N-Dihexyl-2-(4-
fluorophenyl)indole-3-
acetamide 
0.7412 2.334E-05 
13 5-fluoro-5'-
deoxyuridine 
1.139 2.02E-11   R(-)-2,10,11-Trihydroxy-N-
propylnoraporphine 
hydrobromide 
0.7419 1.246E-09 
14 Flumazenil 1.138 1.31E-13   Lidocaine N-ethyl bromide 
quaternary salt 
0.7449 5.537E-31 
15 Famotidine 1.138 4.22E-11   L-3,4-
Dihydroxyphenylalanine 
0.7478 3.461E-08 
16 Fenoterol 
hydrobromide 
1.137 3.3E-08   Etodolac 0.7538 7.702E-06 
17 Pyrilamine maleate 1.137 4.62E-07   1-
Aminocyclopropanecarboxy
lic acid hydrochloride 
0.7555 5.385E-22 
18 Dopamine 
hydrochloride 
1.137 2.38E-07   1-(m-Chlorophenyl)-
biguanide hydrochloride 
0.7618 1.375E-12 
19 PPADS 1.136 8.56E-08   SCH-28080 0.7649 1.315E-08 
20 Putrescine 
dihydrochloride 
1.135 2.14E-11   Doxazosin mesylate 0.7668 7.075E-06 
Table 3.3: The top 20 compounds that elicited an increase or a decrease in the observed ratio of 
compound-treated GFP compared to control GFP from the TIF2p-GFP screen (LHS and RHS 
respectively). Compounds were only deemed significant if their associated Q values were <0.01 
(Q value calculation as described in sections 2.2.3.4 and 3.3.1). Compounds marked with an 
asterisk denote those compounds which appear in both t=0 and t=4 hours.  
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3.3.2.3 Comparison of TIF1p-GFP and TIF2p-GFP screens 
As ascertained by the Wilcoxon rank sum test (α = 0.01) eight compounds were identified 
to give fluorescence intensity outside of the arbitrarily chosen threshold of compound-
treated GFP: control GFP; above 1.2 and below 0.8, for both the TIF1 and TIF2 screens. All 
eight compounds were identified below the 0.8 threshold for both TIF1 and TIF2 (see 
Table 3.4): no compounds were found to be above the threshold of 1.2 in both screens 
and no compounds were identified as causing an up regulation in one screen and down 
regulation in the other. 
# Label GFP/Ave Qvalue  Label GFP/Ave Qvalue 
1 8-Cyclopentyl-1,3-
dimethylxanthine 
0.5426 1.83E-44   8-Cyclopentyl-1,3-
dimethylxanthine 
0.4309 7.473E-27 
2 DNQX 0.6196 9.03E-90   DNQX 0.7111 1.504E-19 
3 Muscimol 
hydrobromide 
0.673 6.27E-80   Muscimol 
hydrobromide 
0.7033 7.403E-20 
4 Etodolac 0.7236 2.34E-17   Etodolac 0.7538 7.702E-06 
5 Dihydro-beta-
erythroidine 
hydrobromide 
0.7413 2.18E-17   Dihydro-beta-
erythroidine 
hydrobromide 
0.7404 5.575E-10 
6 1-(m-Chlorophenyl)-
biguanide 
hydrochloride 
0.7604 4.25E-43   1-(m-Chlorophenyl)-
biguanide 
hydrochloride 
0.7618 1.375E-12 
7 R(-)-2,10,11-
Trihydroxy-N-
propylnoraporphine 
hydrobromide 
0.7703 1.45E-09   R(-)-2,10,11-
Trihydroxy-N-
propylnoraporphine 
hydrobromide 
0.7419 1.246E-09 
8 Doxazosin mesylate 0.7769 5.59E-10   Doxazosin mesylate 0.7668 7.075E-06 
Table 3.4: Compounds that elicited a decrease in the observed ratio of compound-treated GFP 
compared to control GFP in both the single TIF1 and TIF2 GFP screens (LHS and RHS 
respectively). Compounds were only deemed significant if their associated Q values were <0.01 
(Q value calculation as described in sections 2.2.3.4 and 3.3.1). 
 
It is interesting to note that although 8-cyclopentyl-1,3-dimethylxanthine was shown to 
elicit a down regulation in GFP expression in both the TIF1p-GFP and TIF2p-GFP screens, 
the structurally related compound 1,3-diethyl-8-phenylxanthine did not. Furthermore, 
1,3-diethyl-8-phenylxanthine was shown to elicit an increase in GFP expression of  
TIF2p-GFP, albeit at the arbitrary threshold not to a statistically significant level.  A brief 
structural comparison indicates the observed changes are possibly compound specific 
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and, along with the other compounds highlighted in table 4.3, are deserving of further 
consideration. 
Figure 3.9 and Figure 3.10 illustrates the comparison between the expression levels of the 
GFP of TIF1p-GFP and TIF2p-GFP as they are subjected to the LOPAC library. Figure 3.9 
contains all compounds of the LOPAC library regardless of the p and Q values ascertained 
by the Wilcoxon rank sum test and Bonferroni corrections respectively. 
 
Figure 3.9: Comparison of the GFP components from the single TIF1p-GFP screen 
compared with that from the TIF2p-GFP screen. Each individual point represents a single 
compound from the LOPAC library with its associated compound-treated GFP: control 
GFP ratio for both the TIF1p-GFP and TIF2p-GFP screen. 
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As previously stated compounds are able to instigate changes in fluorescence by a 
plethora of mechanisms, many of which relate to modulation of the GFP signal and are 
not a gene regulated mechanism. An inherent level of compound fluorescence was one 
mechanism postulated in the cases of SB 216763 and SU 5416. For ease of comparison 
between the single GFP strains these compounds have been removed from the following 
comparison (the difference between Figure 3.9 and Figure 3.10). 
 
Figure 3.10: Comparison of the GFP components from the single TIF1p-GFP screen 
compared with that from the TIF2p-GFP screen. This figure is the same data set as Figure 
3.9 but with a restricted range as both SB 216763 and SU 5416 were removed from this 
data set (see above). Each individual point represents a single compound from the LOPAC 
library with its associated compound-treated GFP: control GFP ratio for both the TIF1p-
GFP and TIF2p-GFP screen. 
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What is not apparent from the figures above, which show the ratio of compound-treated 
fluorescence to control fluorescence, is that of these two duplicate genes TIF2 is more 
highly expressed (Comparison from these screens indicated TIF2 was expressed ~1.8 x the 
levels exhibited by TIF1). Subsequently Myricetin and Mainserin hydrochloride, which 
were observed supressing the GFP signal in the TIF1p-GFP screen ( the two data points 
farthest left on the above plots), were potentially not identified in both screens as the 
more highly expressed system is innately suited to buffer out small variations.  
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3.3.3 Dual Fluorescent GFP/RFP screening – Reading at 4 Hours 
As previously stated, genetic redundancy between duplicate genes presents a major 
hurdle as the application of standard techniques may not have a noticeable effect due to 
the functional substitution of the duplicate gene. Therefore in order to dissect eIF4A’s 
role as a part of the yeast translational machinery whilst maintaining total transparency, 
all manifestations of the genes encoding eIF4A, namely TIF1 and TIF2, were evaluated in a 
single environment.  
Although this studies primary aim, to evaluate whether TIF1 and TIF2 can be individually 
regulated by small molecule intervention, can be achieved by the development and 
screening of TIF1p-RFP TIF2p-GFP (presented in section 3.3.3.3), the reliance of the 
reporter strains on a plasmid based TIF1-RFP introduces the unknown disparities 
between the genomic architecture of chromosomal and plasmid borne expression 
systems. The second strain, TIF1p-RFP TIF1p-GFP, was generated to investigate this 
disparity; the result of which are presented in section 3.3.3.1. 
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3.3.3.1 TIF1p-GFP TIF1p-RFP Screen 
3.3.3.1.1 TIF1p-GFP component 
Of the compounds screened against TIF1p-GFP TIF1p-RFP 209 compounds, as ascertained 
by the Wilcoxon rank sum test (α = 0.01), elicited a significant increase in GFP expression 
when compared with control GFP. However, 106 compounds were unearthed in the same 
screen at the initial time point. Conversely, 367 compounds elicited a significant decrease 
in GFP expression when compared with control GFP with 213 compounds identified at 
the initial time point. 
Using an arbitrary established threshold of compound-treated GFP: control GFP ratio to 
constitute positive hits; above 1.2 and below 0.8, 13 compounds increased GFP 
expression whilst 1 decreased GFP expression. Of these 14 compounds, 8 compounds 
(ellipticine, ethosuximide, GW2974, idarubicin, L-765,314, quinacrine dihydrochloride, SB 
216763, SU 5416) were identified as causing an upregulation in fluorescence intensity at 
both four hour and initial time points. Although identified as statistically significant by the 
Wilcoxon rank sum test (α = 0.01), these compounds were removed from detailed 
consideration here for the reasons outlined in section 3.3. However, in future studies 
they will be deserving of consideration. 
 
59 
 
 
Figure 3.11: Whole cell fluorescence intensities of the GFP component of TIF1p-GFP TIF1p-RFP 
treated with the LOPAC library (compounds 1 – 1280) compared against the pooled collection 
of whole cell fluorescence intensities of TIF1p-GFP TIF1p-RFP treated with DMSO (as described 
in section 2.2.3.4). (A) Compound-treated GFP: control GFP for the entire LOPAC library ranging 
from highest to lowest. The top 20 compounds that (B) elicited an increase in or (C) elicited a 
decrease in the ratio of compound-treated GFP compared to control. Compounds highlighted in B 
and C are presented in Table 3.5. 
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# Compound 
Compound GFP 
: Control GFP 
Q value  Compound 
Compound GFP 
: Control GFP 
Q  value 
1 SB 216763 * 7.229 3.9E-107   Ro 16-6491 hydrochloride 0.7344 3.403E-17 
2 SU 5416 * 6.18 7.2E-101   CGS-12066A maleate 0.811 3.233E-62 
3 Ethosuximide * 3.124 1.21E-13   DNQX 0.8212 3.688E-48 
4 4-Amino-1,8-
naphthalimide 
2.807 1.37E-63   Droperidol 0.8348 8.963E-37 
5 GW2974 * 2.086 4.8E-154   1-(m-Chlorophenyl)-
biguanide hydrochloride 
0.8354 2.695E-36 
6 Idarubicin * 1.448 2.2E-110   N6-Cyclohexyladenosine 0.8361 2.248E-62 
7 Quinacrine 
dihydrochloride 
*  
1.384 1.3E-131   Doxylamine succinate 0.8385 1.757E-48 
8 Emodin 1.347 8.79E-33   Dextromethorphan 
hydrobromide 
monohydrate 
0.8418 1.195E-69 
9 El l ipticine * 1.34 9.8E-06   SB 203186 0.8429 2.964E-35 
10 L-765,314 * 1.34 1.53E-30   CP55940 0.855 1.478E-48 
11 Sanguinarine 
chloride 
1.307 2.2E-123   Gl ipizide 0.8551 3.578E-35 
12 SU 4312 1.296 7.91E-61   4'-Chloro-3-alpha-
(diphenylmethoxy)tropane 
hydrochloride 
0.862 5.913E-33 
13 GW7647 1.248 5.5E-18   (±)-2-Amino-7-
phosphonoheptanoic acid 
0.8643 2.71E-14 
14 Tyrphostin 47 1.17 4.03E-40   2',3'-didehydro-3'-
deoxythymidine 
0.8651 6.837E-54 
15 Dequalinium 
analog, C-14 
l inker 
1.141 1.48E-75   Di l tiazem hydrochloride 0.8661 1.42E-55 
16 Gl ibenclamide 1.129 1.41E-10   5,5-Dimethyl-1-pyrroline-
N-oxide 
0.8664 2.271E-43 
17 2,3-Dimethoxy-
1,4-
naphthoquinon
e 
1.126 2.31E-51   S(-)-Pindolol 0.8667 2.168E-31 
18 T-1032 1.124 3.12E-38   Y-27632 dihydrochloride 0.8741 1.463E-42 
19 LY-367,265 1.119 5.6E-50   WB-4101 hydrochloride 0.8743 1.365E-46 
20 1,1-Dimethyl-4-
phenyl-
piperazinium 
iodide 
1.118 7.58E-46   Doxepin hydrochloride 0.8766 2.065E-53 
Table 3.5: The top 20 compounds that elicited an increase or a decrease in the observed ratio of 
compound-treated GFP compared to control GFP from the TIF1p-GFP TIF1p-RFP screen (LHS and 
RHS respectively). Compounds were only deemed significant if their associated Q values were 
<0.01 (Q value calculation as described in sections 2.2.3.4 and 3.3.1). Compounds marked with an 
asterisk denote those compounds which appear in both t=0 and t=4 hours. 
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3.3.3.1.2 TIF1p-RFP component 
Of the compounds screened against TIF1p-GFP TIF1p-RFP 104 compounds, as ascertained 
by the Wilcoxon rank sum test (α = 0.01), elicited a significant increase in RFP expression 
when compared with control RFP. However, 15 compounds were unearthed in the same 
screen at the initial time point. Conversely, 95 compounds elicited a significant decrease 
in RFP expression when compared with control RFP with 11 compounds identified at the 
initial time point.  
Using an arbitrary established threshold of compound-treated RFP: control RFP ratio to 
constitute positive hits; above 1.2 and below 0.8, 37 compounds increased RFP 
expression whilst 30 decreased RFP expression. Of these 67 compounds, 2 compounds; 
cyclophosphamide monohydrate and metrifudil, were identified as causing an 
upregulation in fluorescence intensity, whilst only diclofenac sodium was identified as 
causing a down regulation in fluorescence intensity at both four hour and initial time 
points. Although identified as statistically significant by the Wilcoxon rank sum test (α = 
0.01), these three compounds were removed from detailed consideration here for 
reasons outlined in section 3.3. However, in future studies they will be deserving of 
consideration.  
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Figure 3.12: Whole cell fluorescence intensities of the RFP component of TIF1p-GFP TIF1p-RFP 
treated with the LOPAC library (compounds 1 – 1280) compared against the pooled collection 
of whole cell fluorescence intensities of TIF1p-GFP TIF1p-RFP treated with DMSO (as described 
in section 2.2.3.4). (A) Compound-treated RFP: control RFP for the entire LOPAC library ranging 
from highest to lowest. The top 20 compounds that (B) elicited an increase in or (C) elicited a 
decrease in the ratio of compound-treated RFP compared to control RFP. Compounds highlighted 
in B and C are presented in Table 3.6. 
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# Compound 
Compound RFP 
: Control RFP 
Q value 
 
Compound 
Compound RFP 
: Control RFP 
Q value 
1 L-Hyoscyamine 1.418 7.27E-18   SB 218795 0.6488 6.946E-09 
2 DL-threo-beta-
hydroxyaspartic 
acid 
1.366 4.56E-08   GYKI 52466 
hydrochloride 
0.7082 0.0001214 
3 H-8 
dihydrochloride 
1.345 3.31E-10   Dequalinium 
dichloride 
0.7121 5.535E-34 
4 CNS-1102 1.331 2.08E-23   Doxylamine succinate 0.717 3.942E-14 
5 2,6-Diamino-4-
pyrimidinone 
1.321 1.19E-13   Dextromethorphan 
hydrobromide 
monohydrate 
0.7195 4.891E-25 
6 Metri fudil * 1.299 7.72E-10   Retinoic acid p-
hydroxyanilide 
0.7219 0.0003869 
7 N6-2-(4-
Aminophenyl)ethyl
adenosine 
1.298 1.28E-06   N6-
Cyclohexyladenosine 
0.7284 1.747E-17 
8 Ro 41-0960 1.293 2.46E-14   Diacylglycerol kinase 
inhibitor I 
0.7338 8.632E-22 
9 CX 546 1.285 8.96E-19   5,5-Dimethyl-1-
pyrrol ine-N-oxide 
0.7345 5.551E-19 
10 RX 821002 
hydrochloride 
1.278 1.01E-10   SB 203186 0.7355 2.111E-10 
11 (±)-Sotalol 
hydrochloride 
1.268 2.8E-11   Diclofenac sodium * 0.7403 1.968E-13 
12 2-
Methylthioadenosi
ne diphosphate 
tri sodium 
1.261 9.27E-07   IMID-4F hydrochloride 0.749 0.0002448 
13 Isoguvacine 
hydrochloride 
1.258 2.19E-05   5-fluoro-5'-
deoxyuridine 
0.7495 1.763E-10 
14 2,3-Dimethoxy-1,4-
naphthoquinone 
1.257 4.63E-18   Hispidin 0.7512 2.181E-05 
15 Xylometazoline 
hydrochloride 
1.245 7.07E-09   2',3'-didehydro-3'-
deoxythymidine 
0.7539 3.404E-21 
16 SR 57227A 1.243 2.15E-09   Cyclothiazide 0.7574 2.079E-21 
17 2-
Methylthioadenosi
ne triphosphate 
tetrasodium 
1.243 7.58E-06   R-(+)-8-Hydroxy-DPAT 
hydrobromide 
0.7643 0.0006394 
18 Amfonelic acid 1.235 3.17E-05   CP55940 0.7691 1.677E-07 
19 R-(+)-7-Hydroxy-
DPAT 
hydrobromide 
1.234 1.91E-06   Doxepin hydrochloride 0.7694 1.736E-14 
20 Rottlerin 1.233 1.27E-09   DNQX 0.7748 2.906E-05 
Table 3.6: The top 20 compounds that elicited an increase or a decrease in the observed ratio of 
compound-treated RFP compared to control RFP from the TIF1p-GFP TIF1p-RFP screen (LHS and 
RHS respectively). Compounds were only deemed significant if their associated Q values were 
<0.01 (Q value calculation as described in section 2.2.3.4 and 3.3.1). Compounds marked with an 
asterisk denote those compounds which appear in both t=0 and t=4 hours.  
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3.3.3.2 Comparison of fluorescent components of TIF1p-GFP TIF1p-RFP 
As ascertained by the Wilcoxon rank sum test (α = 0.01) only 4-amino-1,8-naphthalimide 
was identified with the fluorescence intensity outside, in this case above, the arbitrarily 
chosen threshold of compound-treated  fluorescence: control fluorescence ratio; for both 
the green and red fluorescently tagged TIF1. It is interesting to note that 4-amino-1,8-
naphthalimide was also shown to upregulate TIF1 in the single TIF1-GFP screen. However, 
due to the total number of cells in each of the quadruplicate wells dosed with 4-amino-
1,8-naphthalimide being lower than the required Acapella threshold for image 
acquisition, data could not collected at time zero. Data became available after 4 hours 
however, as each strain replicated during this incubation period and the total number of 
cells rose above the threshold required for image acquisition.  As discussed in section 3.3, 
without this level of control it was impossible to experimentally determine whether the 
increase in fluorescence intensity, in response to 4-amino-1,8-naphthalimide, is because 
of a gene regulation response or from either intrinsic fluorescence of  
4-amino-1,8-naphthalimide or some compound induced disturbances to fluorescent 
signal. However, as literature reveals that 4-amino-1,8-naphthalimide is in fact a 
fluorophore which emits within the green spectrum, 4-amino-1,8-naphthalimide will not 
be considered further (Parkesh, Clive Lee et al. 2007).    
Figure 3.13 and Figure 3.14 illustrates the comparison between the expression levels of 
the GFP and RFP components of TIF1p-GFP TIF1p-RFP as they are subjected to the LOPAC 
library. Figure 3.13 contains all compounds of the LOPAC library regardless of the p and Q 
values ascertained by the Wilcoxon rank sum test and Bonferroni corrections 
respectively. 
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Figure 3.13: Comparison of the GFP and RFP components from the TIF1p-GFP TIF1p-RFP 
LOPAC library screen. Each individual point represents a single compound from the 
LOPAC library with its associated compound-treated GFP: control GFP ratio and 
compound-treated RFP: control RFP ratio for the GFP and RFP components respectively 
of TIF1p-GFP TIF1p-RFP. 
 
As stated in section 3.3, compounds are able to instigate changes in fluorescence by a 
number of mechanisms and in regards to SB 216763 and SU 5416 it was postulated that 
an inherent level of compound fluorescence may be responsible. For ease of comparison 
these compounds have been removed from the following comparison (the difference 
between Figure 3.13 and Figure 3.14).  
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Figure 3.14: Comparison of the GFP and RFP components from the TIF1p-GFP TIF1p-RFP 
LOPAC library screen. This figure is the same data set as Figure 3.13 but with a restricted 
range as both SB 216763 and SU 5416 were removed from this data set (see above).  Each 
individual point represents a single compound from the LOPAC library with its associated 
compound-treated GFP: control GFP ratio and compound-treated RFP: control RFP ratio 
for the GFP and RFP components respectively of TIF1p-GFP TIF1p-RFP. 
 
From the remaining dataset the only notable compound, other than 4-amino-1,8-
naphthalimide, which falls close to the arbitrarily threshold of compound-treated  
fluorescence: control fluorescence ratio for both the green and red fluorescently tagged 
TIF1 is ethosuximide. Interestingly ethosuximde was shown to elicit an upregulation in 
the GFP component but a down regulation in the RFP component (compound-treated   
fluorescence: control fluorescence of 3.12 and 0.80 respectively). Furthermore it was 
found that in only the GFP component ethosuximde was highlighted as a hit at both the 
four and zero hour time points. A brief structural investigation suggests ethosuximde is 
not inherently fluorescent however; it is possible that ethosuximde may be able to 
modulate and enhance the GFP signal by other methods and subsequently deserving of 
further consideration.  
It is important to note the relatively poor model fit illustrated by the parameters in Figure 
3.13 and Figure 3.14. The gradient suggests that there is some proportionality, but not 
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close to the ideal 1:1 ratio between RFP change and GFP change, whilst the intercept 
suggests that there would be GFP present even if RFP was brought to zero.  Additionally it 
appears that the removal of the fluorescent compounds SB 216763 and SU 5416, which 
are outliers in this system, results in a gradient even further removed from a the ideal 1:1 
ratio. This poor model fit makes it inadvisable to construct any decisive conclusion from 
these observations. However the above figures do eloquently illustrate that the RFP 
signal from TIF1-RFP is weaker than that observed for the GFP equivalent, as was stated 
in section 3.2. 
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3.3.3.3 TIF2p-GFP TIF1p-RFP Screen 
3.3.3.3.1 TIF2p-GFP component 
Of the compounds screened against TIF2p-GFP TIF1p-RFP 66 compounds, as ascertained 
by the Wilcoxon rank sum test (α = 0.01), elicited a significant increase in GFP expression 
when compared with control GFP. However, 72 compounds were unearthed in the same 
screen at the initial time point. Conversely, 174 compounds elicited a significant decrease 
in GFP expression when compared with control GFP with 73 compounds identified at the 
initial time point.  
Using an arbitrary established threshold of compound-treated GFP: control GFP ratio to 
constitute positive hits; above 1.2 and below 0.8, 12 compounds increased GFP 
expression whilst none decreased GFP expression. Of these 12 compounds only, 1-(4-
fluorobenzyl)-5-methoxy-2-methylindole-3-acetic acid and quinacrine dihydrochloride 
were found to upregulate fluorescence intensity at the four hour time point and not time 
zero. The remaining 10 compounds, although identified as statistically significant by the 
Wilcoxon rank sum test (α = 0.01), were removed from detailed consideration here for 
reasons outlined in section 3.3. However, in future studies they will be deserving of 
consideration. 
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Figure 3.15: Whole cell fluorescence intensities of the GFP component of TIF2p-GFP TIF1p-RFP 
treated with the LOPAC library (compounds 1 – 1280) compared against the pooled collection 
of whole cell fluorescence intensities of TIF2p-GFP TIF1p-RFP treated with DMSO (as described 
in section 2.2.3.4). (A) Compound-treated GFP: control GFP for the entire LOPAC library ranging 
from highest to lowest. The top 20 compounds that (B) elicited an increase in or (C) elicited a 
decrease in the ratio of compound-treated GFP compared to control GFP. Compounds highlighted 
in B and C are presented in Table 3.7. 
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# Compound 
Compound GFP 
: Control GFP 
Q value 
 
Compound 
Compound GFP 
: Control GFP 
Q value 
1 SU 5416 * 8.084 4.83E-91   SKF-525A 
hydrochloride 
0.8212 9.459E-19 
2 SB 216763 * 7.518 1.03E-57   DNQX 0.8278 6.194E-18 
3 Emodin * 5.378 1.11E-73   1-(m-
Chlorophenyl)-
biguanide 
hydrochloride 
0.8296 4.49E-18 
4 4-Amino-1,8-
naphthalimide * 
2.606 4.61E-52   Droperidol 0.8391 2.227E-18 
5 Sanguinarine chloride 
* 
1.971 2.35E-34   Minoxidil 0.8404 7.117E-22 
6 Papaverine 
hydrochloride * 
1.773 2.69E-42   L-Canavanine 
sul fate 
0.8404 1.236E-10 
7 Idarubicin * 1.733 2.13E-84   1,7-
Dimethylxanthine 
0.842 4.367E-20 
8 Nyl idrin hydrochloride 
* 
1.618 1.07E-35   Haloperidol 0.8504 3.437E-16 
9 Tyrphostin 47 * 1.364 0.000456   6(5H)-
Phenanthridinone 
0.8542 3.221E-20 
10 SU 4312 * 1.306 2.29E-14   Phenylbutazone 0.8566 6.598E-26 
11 1-(4-Fluorobenzyl)-5-
methoxy-2-
methyl indole-3-acetic 
acid 
1.22 5.11E-30   Praziquantel 0.8627 5.648E-13 
12 Quinacrine 
dihydrochloride 
1.215 4.52E-42   DD1 0.8655 5.557E-09 
13 GW5074 1.178 0.000108   Protriptyl ine 
hydrochloride 
0.8666 7.171E-20 
14 Pyridostigmine 
bromide 
1.154 8.1E-15   (±)-Ibotenic acid 0.8687 5.456E-15 
15 GW2974 1.127 1.3E-08   Danazol 0.869 1.302E-13 
16 2,2'-Bipyridyl 1.123 1.49E-13   (±)-Bay K 8644 0.8699 1.396E-18 
17 Agroclavine 1.121 1.47E-10   Doxylamine 
succinate 
0.8724 2.405E-13 
18 Propentofylline 1.115 1.5E-09   Protoporphyrin IX 
disodium 
0.8755 6.379E-15 
19 Tetramisole 
hydrochloride 
1.112 2.94E-06   Nal idixic acid 
sodium 
0.8757 1.062E-14 
20 Prochlorperazine 
dimaleate 
1.109 1.22E-11   3'-Azido-3'-
deoxythymidine 
0.8761 7.262E-10 
Table 3.7: The top 20 compounds that elicited an increase or a decrease in the observed ratio of 
compound-treated GFP compared to control GFP from the TIF2p-GFP TIF1p-RFP screen (LHS and 
RHS respectively). Compounds were only deemed significant if their associated Q values were 
<0.01 (Q value calculation as described in section 2.2.3.4 and 3.3.1). Compounds marked with an 
asterisk denote those compounds which appear in both t=0 and t=4 hours.  
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3.3.3.3.2 TIF1p-RFP component 
Of the compounds screened against TIF2p-GFP TIF1p-RFP 40 compounds, as ascertained 
by the Wilcoxon rank sum test (α = 0.01), elicited a significant increase in RFP expression 
when compared with control RFP. However, 16 compounds were unearthed in the same 
screen at the initial time point. Conversely, 20 compounds elicited a significant decrease 
in RFP expression when compared with control RFP with 15 compounds identified at the 
initial time point.  
Using an arbitrary established threshold of compound treated RFP: control RFP ratio to 
constitute positive hits; above 1.2 and below 0.8, 28 compounds increased RFP 
expression whilst 17 decreased RFP expression. Of these 45 compounds only, 3-amino-1-
propanesulfonic acid sodium salt and Apigenin were found to upregulate fluorescence 
intensity at the four and zero hour time points. These compounds, although identified as 
statistically significant by the Wilcoxon rank sum test (α = 0.01), were removed from 
detailed consideration here for the reasons outlined in section 3.3. However, in future 
studies they will be deserving of consideration. 
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Figure 3.16: Whole cell fluorescence intensities of the RFP component of TIF2p-GFP TIF1p-RFP 
treated with the LOPAC library (compounds 1 – 1280) compared against the pooled collection 
of whole cell fluorescence intensities of TIF2p-GFP TIF1p-RFP treated with DMSO (as described 
in section 2.2.3.4). (A) Compound-treated RFP: control RFP for the entire LOPAC library ranging 
from highest to lowest. The top 20 compounds that (B) elicited an increase in or (C) elicited a 
decrease in the ratio of compound-treated RFP compared to control RFP. Compounds highlighted 
in B and C are presented in Table 3.8. 
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# Compound 
Compound RFP 
: Control RFP 
Q value 
 
Compound 
Compound RFP 
: Control RFP 
Q value 
1 Cytos ine-1-beta-D-
arabinofuranoside 
hydrochloride 
3.026 2.14E-17   L-Canavanine 
sul fate 
0.5026 0.001666 
2 1-Aminobenzotriazole 2.625 4.34E-32   DNQX 0.5101 1.498E-06 
3 3-Amino-1-
propanesulfonic acid 
sodium * 
2.489 1.41E-19   Droperidol 0.5417 5.921E-08 
4 Calcimycin 2.144 1.53E-09   Haloperidol 0.5814 0.0006219 
5 R(+)-SCH-23390 
hydrochloride 
1.917 3.55E-13   GBR-12909 
dihydrochloride 
0.6118 9.836E-05 
6 Emetine 
dihydrochloride 
hydrate 
1.846 0.0004   2',3'-didehydro-3'-
deoxythymidine 
0.6568 0.002338 
7 Flecainide acetate 1.823 0.000387   Dequalinium 
dichloride 
0.673 5.227E-07 
8 Emodin 1.796 9.26E-25   SKF-525A 
hydrochloride 
0.676 0.008944 
9 DM 235 1.773 0.003283   N-Methyldopamine 
hydrochloride 
0.7018 0.003531 
10 Ouabain 1.585 1.11E-10   S(-)-3PPP 
hydrochloride 
0.7121 0.002627 
11 Apigenin * 1.523 0.003383   Chlorothiazide 0.7217 0.003485 
12 Thapsigargin 1.505 0.000502   trans -Azetidine-
2,4-dicarboxylic 
acid 
0.7446 4.648E-12 
13 Fluspirilene 1.474 0.000155   Phenelzine sulfate 0.7551 0.001337 
14 Nyl idrin hydrochloride 1.442 7.69E-07   AGN 192403 
hydrochloride 
0.7552 8.369E-07 
15 (-)-cis-(1S,2R)-U-50488 
tartrate 
1.393 0.005407   6(5H)-
Phenanthridinone 
0.7618 0.005569 
16 N-Oleoylethanolamine 1.374 2.94E-07   Sul faphenazole 0.7715 0.0002526 
17 Vinblastine sulfate salt 1.374 0.001599   Acetohexamide 0.7853 0.00162 
18 2,3-Dimethoxy-1,4-
naphthoquinone 
1.374 0.000773   Cefazolin sodium 0.8051 0.004663 
19 SR-95531 1.348 0.004882   5'-N-Methyl  
carboxamidoadeno
s ine 
0.8088 0.005654 
20 Zardaverine 1.332 0.004505   Chloroethylclonidin
e dihydrochloride 
0.8166 0.005532 
Table 3.8: The top 20 compounds that elicited an increase or a decrease in the observed ratio of 
compound-treated RFP compared to control RFP from the TIF2p-GFP TIF1p-RFP screen (LHS and 
RHS respectively). Compounds were only deemed significant if their associated Q values were 
<0.01 (Q value calculation as described in section 2.2.3.4 and 3.3.1). Compounds marked with an 
asterisk denote those compounds which appear in both t=0 and t=4 hours.  
 
 
74 
 
3.3.3.4 Comparison of fluorescent components of TIF2p-GFP TIF1p-RFP 
As ascertained by the Wilcoxon rank sum test (α = 0.01) three compounds; emodin, 
nylidrin hydrochloride, and papaverine hydrochloride, were identified as inducing 
fluorescence intensity above the arbitrarily chosen threshold of compound-treated 
fluorescence: control fluorescence; for both the fluorescent protein components of 
TIF2p-GFP TIF1p-RFP. However as stated in section 3.3.3.3.1, all three compounds were 
identified as causing an upregulation in fluorescence intensity of the GFP component of 
TIF2p-GFP TIF1-RFP, at both the four and zero hour time points. Thus, these compounds 
were removed from detailed consideration here for the reasons outlined in section 3.3.  
Figure 3.17 illustrates the comparison between the expression levels of the GFP and RFP 
components of TIF2p-GFP TIF1p-RFP once subjected to the LOPAC library. It contains all 
compounds of the LOPAC library regardless of the p and Q values ascertained by the 
Wilcoxon rank sum test and Bonferroni corrections respectively. 
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Figure 3.17: Comparison of the GFP and RFP components from the TIF2p-GFP TIF1p-RFP 
LOPAC library screen. Each individual point represents a single compound from the 
LOPAC library with its associated compound-treated GFP: control GFP ratio and 
compound RFP: control RFP ratio for the GFP and RFP components respectively of  
TIF2p-GFP TIF1p-RFP. 
 
As stated in section 3.3, compounds are able to instigate changes in fluorescence by a 
number of mechanisms and in regards to SB 216763, SU 5416 and 4-amino-1,8-
naphthalimide (the three highest data points on the y axis) it was postulated that an 
inherent level of compound fluorescence may be responsible. For ease of comparison 
these compounds, have been removed from the following comparison. Additionally, 
literature indicates that emodin is itself fluorescent, thus, for ease of comparison, Figure 
3.18 was generated to also exclude emodin from its viewing range (Pecere, Gazzola et al. 
2000; Hernandez, Recio et al. 2012). 
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Figure 3.18: Comparison of the GFP and RFP components from the TIF2p-GFP TIF1p-RFP 
LOPAC library screen. This figure is the same data set as Figure 3.17 but with a restricted 
range as SB 216763, SU 5416, 4-amino-1,8-naphthalimide and emodin were removed 
from this data set (see above). Each individual point represents a single compound from 
the LOPAC library with its associated compound-treated GFP: control GFP ratio and 
compound-treated RFP: control RFP ratio for the GFP and RFP components respectively 
of TIF2p-GFP TIF1p-RFP. 
 
Encouragingly, the gradient suggests that there is no strong relationship between RFP 
change and GFP change (Once the aforementioned fluorophores were removed).  
If we consider that the RFP component of TIF2-GFP TIF1-RFP, TIF1 has a far greater 
number of hits than the TIF2 component, 43 and 2 compounds respectively (see section 
3.3.3.3.1 and 3.3.3.3.2), then we can speculate the implications with regards to the roles 
of the paralogous genes. In the cell eIF4A is present at very high concentrations and as 
such the more highly expressed TIF2 may be constitutively activated at level approaching 
its potential maximum. Upon probing with the LOPAC library, TIF2 appears to be less able 
to effect change in the eIF4A levels than TIF1 as seen by the number of hits generated for 
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each component. Therefore we can speculate, if we ignore all the noted problems with 
this system, that the responsibility for promoting change in eIF4A levels in response to 
chemical intervention was  achieved by regulation of the generally lesser expressed TIF1.   
This result not only illustrates that the two genes can be individually identified in the one 
environment but illustrates the importance of all mRNA regulatory domains. It is likely 
that this intervention is causing regulation differences due to uncharacterised sequence 
elements in the 5’ and 3’ UTR ( an array of which were described in section 1.4) however, 
it would be unwise to completely rule out the role of the six synonymous changes in the 
two genes coding sequence. It is possible that these compounds are selectively increasing 
or decreasing the delivery of TIF1-specific tRNA based on these synonymous amino acid 
substitutions.  
It is important to note that both of the compounds shown to upregulate the TIf2p-GFP 
component of TIF2-GFP TIF1-RFP; 1-(4-fluorobenzyl)-5-methoxy-2-methylindole-3-acetic 
acid and quinacrine dihydrochloride present  only modest fluorescence increases. A brief 
structural analysis indicates these compounds may themselves be fluorescent and the 
apparent upregulation seen is possibly as result of an accumulation of these fluorescent 
compounds. Furthermore literature indicates that quinacrine dihydrochloride is itself 
fluorescent and has been used previously as a fluorescent probe (Lee 1971; Pearson, 
Bobrow et al. 1971). 
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3.3.3.5 Multiple Screen comparison 
It is important to note that when comparing all other combination of the four screens 
described above; TIF1-GFP against the GFP component from TIF1-GFP TIF1-RFP, TIF2-GFP 
against the GFP component from TIF2-GFP TIF1-RFP, there is no overlap in any of the 
compounds that are shown to significantly increase or decrease fluorescence intensity 
outside the arbitrary threshold range, except for the combination described below.  
3.3.3.5.1 Plasmid RFP comparison 
As ascertained by the Wilcoxon rank sum test (α = 0.01) five compounds were identified 
as regulating fluorescence intensity above or below the arbitrarily chosen threshold of 
compound-treated fluorescence: control fluorescence; for both the plasmid RFP 
component of TIF2p-GFP TIF1p-RFP and TIF1p-GFP TIF1p-RFP. Of these compounds, 2,3-
dimethoxy-1,4-naphthoquinone and thapsigargin elicited an upregulation in fluorescence 
intensity, whilst DNQX, 2',3'-didehydro-3'-deoxythymidine and dequalinium dichloride 
elicited a down regulation in fluorescence intensity for both plasmid RFP components. 
Figure 3.19 illustrates the comparison between the expression levels of the RFP 
components of TIF1p-GFP TIF1p-RFP and TIF2p-GFP TIF1p-RFP as they are subjected to 
the LOPAC library. It contains all compounds of the LOPAC library regardless of the p and 
Q values ascertained by the Wilcoxon rank sum test and Bonferroni corrections 
respectively. 
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Figure 3.19 : Comparison of the RFP components from the TIF1p-GFP TIF1p-RFP screen 
compared with that from the TIF2p-GFP TIF1p-RFP screen.  Each individual point represents a 
single compound from the LOPAC library with its associated compound-treated RFP: control RFP 
ratio for both the RFP components of TIF1p-GFP TIF1p-RFP and TIF2p-GFP TIF1p-RFP. 
 
It is important to note that a small number of compounds appear to generate change in 
abundance of TIF1p-RFP in the TIF2p-GFP TIF1p-RFP strain but not in the TIF1p-GFP 
TIF1p-RFP equivalent when we ideally should see a clustering of hits. Since TIF1p-RFP is 
common to both strains, this may be an experimental artefact or may arise from 
underlying differences around the second source of Tif1p in these strains, with the TIF1-
GFP having a disrupted 3’ untranslated region and a protein product that may be less 
efficiently converted to a functional protein product due to the presence of the GFP tag.  
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3.4 Advantages and limitations of this screen 
3.4.1 Advantages 
The major advantages of the fluorescence based system constructed during this study is 
the ease with which this system can be manipulated and so is applicable to any ORF in 
the S. cerevisiae genome, under a number of interchangeable selection markers as well as 
providing the ability to be analysed by a diverse set of methodologies. Furthermore, this 
system was designed with a view to eliminating some of the problems associated with 
other commercially available fluorescent markers. 
3.4.1.1 Universal application of plasmid borne ORF-RFP  
The primer system employed in this research was designed so that in any future studies 
these existing primers are able to be easily modified allowing any gene in the genome to 
be fused with the RFP RedStar2. The specific primer system utilised in the creation of 
TIF1-RFP is outlined in Table 3.9.  
Table 3.9: The primer set used in the construction of TIF1-RFP colour coded to highlight the 
origin of each component that makes up the three modules: Red – RFP RedStar2, green – 
pRS316, black – TIF1. 
 
This primer system can be amended to suit any ORF by replacing the black (TIF1) 
sequences with sequences from the desired ORF that are equivalent to the TIF1 ORF, 
Identification 
Number 
Primer Sequence 
#484 Module 1 
Forward 
CAGTCACGACGTTGTAAAACGACGGCCAGTGAATTGTAATTC
AGCAACAACATCCGATGCTT 
#485 Module 1 
Reverse 
ACCTGCACCAGCTCCAGCTCCGTTCAACAAAGTAGCGATGTCG
GATGGCAATTCTTCAATTT 
#486 Module 2 
Forward 
AATTGAAGAATTGCCATCCGACATCGCTACTTTGTTGAACGGA
GCTGGAGCTGGTGCAGG 
#378 Module 2 
Reverse 
TAGCCTCACAAGATACTTTTTTAAGAAGTTTTTGTCTCCCTTAC
AAGAACAAGTGGTGTC 
#487 Module 3 
Forward 
ACTGAAGGTAGACACCACTTGTTCTTGTAAGGGAGACAAAAA
CTTCTTAAAAAAGTATCTTGTGAGGCTATCTTG 
#488 Module 3 
Reverse A 
CGGCTCCTATGTTGTGTGGAATTGTGAGCGGATAACAATTTTT
GATGTACACTTTTTCTTTTCAG 
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TIF1pr and TIF1tr regions illustrated in Figure 3.1 and outlined in section 3.1.1. 
Additionally as discussed in section 3.2 specific care must be taken when incorporating 
the upstream and downstream sections of the desired gene so as to incorporate all 
regions that have been previously categorised as active. 
To be truly a universally interchangeable system these primers, once amended to suit any 
ORF in the genome have to maintain two essential functions. The first of which is  creation 
of modules that incorporate the desired ORF, RFP and plasmid, and secondly that these 
modules successfully allow transformation into a parental yeast strain via homologous 
recombination. These two functions can roughly be achieved by selecting regions of the 
desired ORF, that at least with regard to gene position, mimic those utilised in this study. 
However, it is possible that the sections utilised are not conducive to successful module 
creation and homologous recombination. In these cases it is possible to amend the 
chosen sequences but a certain sequence length must be maintained to ensure successful 
homologous recombination. 
Hua et al., (1997) investigated the length of homology required for successful 
transformation of a functional plasmid. They identified the percentage of 2-micron 
plasmids, of ~2 kb in length bearing a Lac Z system, that following transformation were 
deemed to be functionally active by a beta-galactosidase activity assay. Hua equated that 
30 bp of homologous sequence at each end of a DNA fragment was sufficient to integrate 
the fragment into a linearized plasmid in yeast (78.9% functionally active transformants). 
However, Hua acknowledged in order to obtain a high yield of active transformants 60 bp 
of sequence homology are desirable (95.8% functionally active transformants). 
Consequently any deviation from the sequence lengths outlined above must maintain at 
least 30bp of sequence homology at the end of each module to ensure successful 
transformation. 
This primer set is not only amendable to universally fit any ORF in the genome but can be 
expressed on a number of different plasmids with varying selection markers.  There is no 
need to manipulate the above sequences further as the CEN plasmid set (discussed in 
section 3.2) all include a multiple cloning site of identical sequence. This multiple cloning 
site incorporates the single copy of the motifs that the restriction enzymes XbaI and 
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HindIII are designated to digest, which allows for the use of a set of interchangeable 
plasmids. The major benefit to this universality is the ease of interchangeably available 
gene-RFP selection markers. This ability allows for a single fusion design to be expressed 
in a wider range of yeast strains as well as avoiding conflicts with selection markers 
rendering strains incompatible with some standard yeast techniques.       
3.4.1.2 Fusion proteins and their endogenous regions 
The yeast GFP clone collection is a set of S. cerevisiae open reading frames tagged at the 
carboxy terminal end using the coding sequence of Aequorea Victoria GFP (S65T GFP). 
This library has 75% coverage of the S. cerevisiae proteome and research utilising it was 
able to classify 4159 yeast GFP clones into one or more of 12 subcellular localisation 
categories (Huh, Falvo et al. 2003). However, this localisation data agrees with only 80% 
of the published data available on the Saccharomyces Genome Database (SGD. 2012).  It 
has been suggested that a potential reason for this discrepancy could have been caused 
by the way the ~27 kDa GFP fusion protein was introduced into the library.  
As illustrated in Figure 3.20, each open reading frame (ORF) was systematically GFP 
tagged in its chromosomal location through oligonucleotide-directed homologous 
recombination. These methodologies lead to the introduction of each GFP tag, and its 
associated HIS3 selection marker, directly after the stop codon of each ORF. This GFP tag 
disrupts the wild type 3’ UTR and may disrupt any transcript localisation motifs located in 
this region. This potential problem may have an effect the GFP components of both dual 
fluorescent proteins which bear this tag and may be a leading cause as to the observed 
discrepancies in protein localisation described by Huh (2003). 
The central dogma suggests that polypeptides will only fold into functional proteins if 
they are allowed to fold in unique domains thus this disruption may affect normal protein 
folding. Furthermore, the GFP source in this library does not have a linker region which is 
conducive to protein folding. However, there is no implication that these issues have an 
effect on either of the TIF genes. 
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Figure 3.20: Strategy for GFP library construction. PCR products containing the GFP tag 
and a selectable marker gene were inserted at the C terminus of each ORF through 
homologous recombination, yielding a C-terminally GFP-tagged protein. Figure from Huh 
(2003). 
 
In order to negate the possibility of creating a TIF1-RFP fusion that was not functionally 
equivalent to the wild type TIF1, as observed in a small percentage of genes in the GFP 
clone collection, a number of prevention measures were adopted. The RFP RedStar2 was 
selected specially in this research as it has an established linker region, before the start of 
the RFP coding sequence, of 10 residues of repeating glycine and alanine molecules. This 
addition gives confidence that the RFP will have a lower hindrance on the TIF1 ORF than 
S65T GFP, used in the GFP clone collection.  
The second prevention method can be interpreted as either an advantage or limitation. In 
order to limit the size of the foreign coding region inserted in the 3’ UTR, the RFP was not 
associated with its own selection maker. Subsequently the presence of the RFP in the 
transformed strains could not be identified by growth under a given selection pressure 
but was identified visually by confocal microscopy.  The initial advantage from this 
method may instantly become redundant if the RFP is not successfully maintained in 
future generations or homogenously across every cell in a strain. However this concern 
84 
 
was alleviated by the observation of satisfactory transmission of plasmid, and subsequent 
RFP expression, between parental and daughter generations.  
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3.4.2 Limitations 
There are two major groupings by which the limitations encountered throughout this 
study can be classified; limitations arising from the methodologies employed in the 
generation of this fluorescence based system and limitations resulting from this  system’s 
application. 
There are three limitations arising from the first category that, even though they 
significantly reduced the concluding power of this research, were all deemed expedient 
to the success of this initial study. Firstly, the retention of a third source of eIF4A in both 
dual fluorescent strains as a result of the retention of an untransformed TIF2-GFP strain. 
Secondly, the unknown disparities of how the architecture of plasmid and chromosomal 
copies of fluorescent proteins effects the production of eIF4A and finally the 
incorporation of an RFP that is not regulated by selection under a specific selection 
pressure. The aforementioned limitations have previously been discussed in section 3.2 
and 3.4.1.2 respectively.  
Additional limitations arose from issues with the screening method. Potentially the 
limitation with the broadest effect on this study is that, due to time constraints for this 
research, no repetition of any of the four screens was completed. From the data obtained 
in these screens there is a notable disparity between the observed levels of significance 
for an individual compound across multiple screens which may plausibly be attributed to 
the Individual fluorescence variation in a single well. Consequently a number of 
compounds considered to be hits that lie on the bubble of the arbitrary significance 
threshold employed in this study may in fact be artefacts. However, as discussed in 
section 3.3.1, the aforementioned threshold was intentionally set to be very stringent to 
limit the inclusion of false positives. 
In addition to above, in some cases fluorescence intensities were deemed to be 
undetectable at time zero but detectable at the second time reading after 4 hours. This 
observation was a consequence of too few cells being delivered into a given well resulting 
in a failed reading by the image recognition software Acapella. As each strain replicated 
during the four hour incubation, during this time fluorescence intensities became 
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distinguishable.  Subsequently this, and the observed disparities in individual variation, is 
likely to be rectified upon completion of a number of screen repetitions. 
In terms of the chosen screening methodology a number of limitations arose due to lack 
of specific controls and counter screens. For example a control (or equivalent counter 
screen) with compound but no fluorescent protein is required in order to account for the 
significant changes observed in response to compounds which were hypothesised as 
having an inherent level of fluorescence. In addition, a dye swap experiment, where the 
fluorescent proteins assigned to each gene of the dual fluorescent reporters are 
swapped, is required in order to eliminate erroneously classified hits that are a result of 
variations in fluorescence intensities attributed to the fluorescent proteins themselves 
and not from compound interaction with TIF1 and TIF2. 
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3.5 Conclusions 
The aim of this study was to contribute to a wider programme into the TIF1 and TIF2 
paralogs, specifically to design a system to reveal whether they could be individually 
regulated by small molecule intervention.  To this end, a set of fluorescent reporter 
strains with plasmid-borne TIF1-RFP were generated.  Although it was expected that 
ultimately the TIF1-RFP would have to be integrated into the genome, the development 
of a set of strains containing the TIF1-RFP on a CEN plasmid was chosen as a realistic 
target for this masters’ project.   
A TIF1-RFP construct containing both 5’ and 3’ UTRs was successful ly generated. 
Transformants made with the construct were viable, stable, and expressed both red and 
green fluorescent proteins effectively.  Extensive screening methodology development 
revealed that high-throughput confocal microscopy was more appropriate than high-
throughput flow cytometry analysis for these strains, but also revealed limitations with 
the plasmid borne system.  Most notable amongst these was the localisation of the RFP-
labelled TIF1p, which was not as evenly distributed through the cytosol as the 
commercially available TIF1p-GFP.  This may be due to high abundance of the protein, 
given that these plasmid-containing TIF1-RFP constructs retain the unlabelled genomic 
TIF1 gene.  Alternatively, TIF1p-RFP may be more accurately reflecting an impact of 3’ 
UTR directing of localisation, since the commercial available TIF1p-GFP strain has its 3’ 
UTR disrupted by selection markers. 
A preliminary screen was undertaken with these reporter strains using the LOPAC library.  
Results from these screens signalled the potential of the dual fluorescent reporter system 
as a tool for the discovery of small molecule regulators of TIF1p or TIF2p. A number of 
important points emerge from this work. Firstly, it is possible to distinguish between 
expression from TIF1 and TIF2 in the same environment. Secondly, the creation of a 
universally applicable plasmid borne gene-RFP fusion was successful and could be more 
broadly applied to the study of duplicate genes. Finally, whilst there were elements of 
overlap between the screens, the more general outcome was a lack of coherence 
between the results from the screens.   
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Although not a specified goal of this project, a useful consequence of the approach was 
the ability to assess how well a plasmid containing a construct including the 5’ and 3’ 
UTRs mimicked the genomic copy of the same gene.  As mentioned above, issues were 
noted with protein localisation of the TIF1p-RFP in some circumstances.  More notably, 
the correlation between components of the dual fluorescent reporter, Tif1p-GFP TIF1p- 
was relatively low (for example, see Figure 3.14). 
Chemoinformatic analysis of compounds causing large and significant apparent changes 
in the abundance of eIF4A from the reporter strains revealed that predominantly such 
changes arose from the chromophoric or fluorophoric nature of the compounds 
identified.  Never-the-less a small number of compounds were identified that could be of 
interest in future study, although there were no structural elements in common between 
these compounds.  
Overall, the study revealed the utility of the system in general terms, and provides a basis 
for the next step, which would be to create a reporter strain bearing a genomic TIF1-RFP 
construct, as well as a “dye-swapped” TIF1-GFP, TIF2-RFP control strain. 
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3.6 Future directions 
There are a vast number of potential uses for the dual fluorescent system designed 
during the course of this study. Initially it would be wise to remedy the aforementioned 
limitations, by the introduction of more stringent controls, increasing the number of 
screen repetitions to at least three, and conducting validation experiments on those 
compounds identified as hits in the four screens, which due to time constraints of this 
research,  could not preformed. However as this thesis as shown prima-facie evidence 
that the differential regulatory patterns of TIF1 and TIF2 can be assessed by a dual 
fluorescent reporter system, it is  appealing to move to incorporating a genomically 
integrated copy of RFP and removal of the unlabelled TIF copy. 
One potentially fruitful avenue arising from this study is an investigation into how the 
architecture of plasmid borne proteins differs from their genomically expressed 
counterparts. This could be achieved upon integration of RFP into the genome, as 
suggested above, and the comparison between this strain and the plasmid borne TIF1-
RFP strain outlined in this thesis.  
As previously noted, TIF1 and TIF2 have an almost identical sequence similarity in their 
coding region, barring six synonymous changes in the gene sequence, and vastly diverse 
sequences in both the 5’ and 3’ UTRs. Therefore it would be profitable to investigate how 
modifications in these regions effect the differential regulation of TIF1 and TIF2. For 
example, to investigate the regulatory effect that codon bias, arising from the six 
synonymous changes has on the two genes ORF the current system can be amended by 
switching the promoter and terminator sequences of one of the TIF genes to mimic the 
other (by methodologies outlined in section 3.4.1.1).  This process of region switching 
could be utilised to investigate the 3’ and 5’ UTR also. 
This system is perfectly suited to validate published results that have been generated by 
indirect evidence, which have suggested certain transcription factors that may cause a 
change in the protein abundance of eIF4A. For example the interaction of the 
transcription factor YAP1 with H2O2 has been suggested, on the freely available online 
resources YEASTRACT, to have an effect TIF1 (Teixeira, Monteiro et al. 2006; Thorsen, 
Lagniel et al. 2007; Monteiro, Mendes et al. 2008; Abdulrehman, Monteiro et al. 2011). 
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However this was generated by inferences from microarray data and needs to be directly 
validated. 
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5 Appendix A – LOPAC Library HTS time zero readings 
As indicated in section 2.2.3.2, readings from the LOPAC library HTS screens were taken 
at time zero and after a four hour incubation period. This methodology was exercised in 
an attempt to enrich the list of “hits” to only include compounds eliciting a response 
resulting from gene regulation.  As the initial time point for imaging is almost 
instantaneously after the introduction of the LOPAC library it is not conceivable that any 
observed changes in protein expression were regulated via changes in mRNA expression. 
Instead, it is plausible that any such changes are instigated by disturbances in the GFP 
signal or arise from intrinsic fluorescence in the compound library and not as a 
consequence of gene expression changes in response to the introduction of the LOPAC 
library. Hence any “hits” observed at the initial time point are considered a crucial control 
in eliminating those compounds that are not pertinent to the primary aim of this study; 
elucidating differential regulation between TIF1 and TIF2. 
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5.1 Single GFP screening 
5.1.1 TIF1p-GFP screen 
 
Figure 5.1: Whole cell fluorescence intensities of TIF1p-GFP treated with the LOPAC library 
(compounds 1 – 1280) compared against the pooled collection of whole cell fluorescence 
intensities of TIF1p-GFP treated with DMSO  at t=0 (as described in section 2.2.3.4). (A) 
Compound-treated GFP: control GFP for the entire LOPAC library ranging from highest to lowest. 
The top 20 compounds that (B) elicited an increase in or (C) elicited a decrease in the ratio of 
compound-treated GFP compared to control. Compounds highlighted in B and C are presented in 
Table 5.1. 
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# Compound 
Compound GFP 
: Control GFP 
Q value 
 
Compound 
Compound GFP 
: Control GFP 
Q value 
1 SB 216763 15.22 4.14E-06   Myricetin 0.3012 1.424E-25 
2 SU 5416 3.537 6.12E-19   Mianserin hydrochloride 0.5254 3.247E-13 
3 Carcinine 
dihydrochloride 
1.52 0.005341   Areca idine propargyl  
ester hydrobromide 
0.6415 7.266E-08 
4 SB 204070 
hydrochloride 
1.408 0.000583   Rp-cAMPS triethylamine 0.7396 0.0002334 
5 Tyrphostin AG 
34 
1.32 9.19E-10   Orphenadrine 
hydrochloride 
0.767 9.374E-08 
6 (6R)-5,6,7,8-
Tetrahydro-L-
biopterin 
hydrochloride 
1.301 1.24E-09   7-Cyclopentyl -5-(4-
phenoxy)phenyl -7H-
pyrrolo[2,3-d]pyrimidin-
4-ylamine 
0.773 0.0002089 
7 1-(4-
Chlorobenzyl)-
5-methoxy-2-
methyl indole-
3-acetic acid 
1.287 0.00227   Caffeic acid phenethyl 
ester 
0.7817 3.117E-06 
8 6,7-ADTN 
hydrobromide 
1.268 0.007032   Sul indac 0.7884 1.057E-05 
9 Taurine 1.261 0.000281   Mesulergine 
hydrochloride 
0.8048 0.0001584 
10 13-cis -retinoic 
acid 
1.235 2.53E-07   El iprodil 0.8049 7.082E-06 
11 R(-)-SCH-12679 
maleate 
1.233 0.000108   MK-886 0.807 0.001026 
12 Tyrphostin AG 
112 
1.224 7.64E-07   Phorbol 12-myristate 13-
acetate 
0.8146 4.798E-12 
13 Reactive Blue 2 1.224 0.000804   XK469 0.8154 0.00822 
14 Spermidine 
trihydrochlorid
e 
1.221 0.000151   Nimustine hydrochloride 0.8164 2.921E-08 
15 Ritodrine 
hydrochloride 
1.217 0.001494   N6-Cyclohexyladenosine 0.8208 1.967E-05 
16 4-
Hydroxyphenet
hylamine 
hydrochloride 
1.213 0.000352   5,7-Dichlorokynurenic 
acid 
0.8212 0.002928 
17 Ritanserin 1.209 0.003655   ci s -(Z)-Flupenthixol 
dihydrochloride 
0.8231 1.145E-14 
18 Cephalothin 
sodium 
1.206 0.005308   S(-)-DS 121 hydrochloride 0.8279 0.0003135 
19 Ro 41-0960 1.203 0.007441   Hydroxytacrine maleate 0.8287 3.751E-07 
20 NG-Nitro-L-
arginine 
1.201 0.00091   Ergocris tine 0.8287 2.619E-10 
Table 5.1: The top 20 compounds that elicited an increase or a decrease in the observed ratio of 
compound-treated GFP compared to control GFP from the TIF1p-GFP screen at t=0 (LHS and 
RHS respectively). Compounds were only deemed significant if  their associated Q values were 
<0.01 (Q value calculation as described in sections 2.2.3.4 and 3.3.1). 
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5.1.2 TIF2p-GFP screen 
 
Figure 5.2: Whole cell fluorescence intensities of TIF2p-GFP treated with the LOPAC library 
(compounds 1 – 1280) compared against the pooled collection of whole cell fluorescence 
intensities of TIF2p-GFP treated with DMSO  at t=0 (as described in section 2.2.3.4). (A) 
Compound-treated GFP: control GFP for the entire LOPAC library ranging from highest to lowest. 
The top 20 compounds that (B) elicited an increase in or (C) elicited a decrease in the ratio of 
compound-treated GFP compared to control. Compounds highlighted in B and C are presented in 
Table 5.2. 
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# Compound 
Compound GFP 
: Control GFP 
Q value 
 
Compound 
Compound GFP 
: Control GFP 
Q value 
1 SU 5416 2.792 6.18E-06   CGP-7930 0.5756 2.946E-06 
2 Naltrindole 
hydrochloride 
1.378 0.000468   Imipramine 
hydrochloride 
0.5758 1.997E-14 
3 NAN-190 
hydrobromide 
1.365 2.62E-06   Dihydroergotamine 
methanesulfonate 
0.6488 1.596E-07 
4 Methiothepin 
mesylate 
1.336 0.00098   Areca idine propargyl  
ester hydrobromide 
0.6602 0.001959 
5 T-0156 1.312 4.05E-05   Ro 16-6491 
hydrochloride 
0.6667 2.587E-13 
6 Nialamide 1.302 0.000753   Fluspirilene 0.7037 4.846E-10 
7 (±)-
Normetanephri
ne 
hydrochloride 
1.297 0.000838   8-(p-
Sul fophenyl )theophylline 
0.7163 0.002497 
8 Spermidine 
trihydrochlorid
e 
1.283 3.13E-05   Tiapride hydrochloride 0.7659 0.0002051 
9 Neostigmine 
bromide 
1.261 0.009829   Ergocris tine 0.7754 2.706E-14 
10 Mibefradil 
dihydrochloride 
1.259 0.000581   PAPP 0.7773 0.0003945 
11 Taurine 1.242 0.003962   Ni trendipine 0.7858 0.000227 
12 Zonisamide 
sodium 
1.241 0.008218   Felodipine 0.7916 3.274E-06 
13 REV 5901 1.229 0.002398   Serotonin hydrochloride 0.7969 0.0003 
14 SR 59230A 
oxalate 
1.226 0.000629   (+)-Hydrastine 0.8106 0.0003053 
15 Tyrphostin AG 
555 
1.221 1.32E-06   7-Cyclopentyl -5-(4-
phenoxy)phenyl -7H-
pyrrolo[2,3-d]pyrimidin-
4-ylamine 
0.8126 0.0000451 
16 Quazinone 1.212 0.002161   (±)-gamma-Vinyl GABA 0.8148 2.523E-08 
17 4-Amino-1,8-
naphthalimide 
1.21 8.14E-05   JWH-015 0.8284 0.002323 
18 Tetrahydrozolin
e hydrochloride 
1.197 0.004263   1-
Aminocyclopropanecarb
oxyl ic acid hydrochloride 
0.844 4.398E-06 
19  Xamoterol 
hemifumarate 
1.18 0.000718   (±)-p-
Chlorophenylalanine 
0.8478 0.0001121 
20 AC 915 oxalate 1.173 0.008797   Es trone 0.8604 0.0004657 
Table 5.2: The top 20 compounds that elicited an increase or a decrease in the observed ratio of 
compound-treated GFP compared to control GFP from the TIF2p-GFP screen at t=0 (LHS and 
RHS respectively). Compounds were only deemed significant if their associated Q values were 
<0.01 (Q value calculation as described in sections 2.2.3.4 and 3.3.1). 
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5.2 Dual Fluorescent GFP/RFP screening 
5.2.1 TIF1p-GFP TIF1p-RFP screen 
 
Figure 5.3:  Whole cell fluorescence intensities of the GFP component of TIF1p-GFP TIF1p-RFP 
treated with the LOPAC library (compounds 1 – 1280) compared against the pooled collection 
of whole cell fluorescence intensities of TIF1p-GFP TIF1p-RFP treated with DMSO  at t=0 (as 
described in section 2.2.3.4). (A) Compound-treated GFP: control GFP for the entire LOPAC 
library ranging from highest to lowest. The top 20 compounds that (B) elicited an increase in or 
(C) elicited a decrease in the ratio of compound-treated GFP compared to control. Compounds 
highlighted in B and C are presented in Table 5.3. 
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Figure 5.4: Whole cell fluorescence intensities of the GFP component of TIF1p-GFP TIF1p-RFP 
treated with the LOPAC library (compounds 1 – 1280) compared against the pooled collection 
of whole cell fluorescence intensities of TIF1p-GFP TIF1p-RFP treated with DMSO  at t=0 (as 
described in section 2.2.3.4). This figure is the same data set as Figure 5.3 but with a restricted 
range as SB 216763, SU 5416, were removed from this data set. (A) Compound-treated GFP: 
control GFP for the entire LOPAC library ranging from highest to lowest. The top responding 
compounds that (B) elicited an increase in or (C) elicited a decrease in the ratio of compound-
treated GFP compared to control. Compounds highlighted in B and C are presented in Table 5.3. 
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# Compound 
Compound GFP 
: Control GFP 
Q value 
 
Compound 
Compound GFP 
: Control GFP 
Q value 
1 SU 5416 119.7 0.000385   HA-100 0.7959 6.682E-18 
2 SB 216763 103.4 7.98E-05   MHPG piperazine 0.8045 3.18E-07 
3 Sodium Oxamate 3.023 1.04E-85   p-MPPF dihydrochloride 0.8136 1.894E-21 
4 GW2974 2.298 5.09E-39   GR 125487 sul famate 
sa lt 
0.8286 3.403E-09 
5 Idarubicin 1.855 1E-10   CR 2249 0.8391 1.155E-08 
6 Quinacrine 
dihydrochloride 
1.675 6.7E-43   Nal idixic acid sodium 0.8425 1.989E-09 
7 U0126 1.666 0.000237   NCS-382 0.8486 0.0006286 
8 Gl ibenclamide 1.596 0.000935   9-cyclopentyladenine 0.8516 2.973E-36 
9 L-765,314 1.483 6.2E-31   erythro-9-(2-Hydroxy-3-
nonyl )adenine 
hydrochloride 
0.8569 4.512E-25 
10 GYKI 52466 
hydrochloride 
1.387 1.18E-06   CL 316,243 0.8594 6.188E-54 
11 Ethosuximide 1.351 0.006546   R(+)-SCH-23390 
hydrochloride 
0.8659 1.223E-23 
12 NF449 
octasodium salt 
1.348 3.9E-05   1-(4-
Hydroxybenzyl)imidazole
-2-thiol 
0.8669 9.788E-07 
13 El l ipticine 1.237 7.46E-16   R(+)-UH-301 
hydrochloride 
0.8687 8.877E-24 
14 JWH-015 1.176 0.000109   beta-Estradiol 0.8696 9.423E-16 
15 3-
Hydroxybenzylhy
drazine 
dihydrochloride 
1.168 8.75E-07   (±)-7-Hydroxy-DPAT 
hydrobromide 
0.8713 0.003167 
16 Sanguinarine 
chloride 
1.155 6.94E-24   HA-1004 hydrochloride 0.8715 0.0008731 
17 Emodin 1.153 8.69E-28   Clofibrate 0.8724 1.829E-35 
18 SU 4312 1.151 8.5E-22   2-Chloro-2-deoxy-D-
glucose 
0.8734 4.585E-22 
19 3',4'-
Dichlorobenzamil 
1.149 3.52E-09   A-77636 hydrochloride 0.874 1.948E-06 
20 Dubinidine 1.139 2.53E-14   O6-benzylguanine 0.8787 9.128E-10 
Table 5.3: The top 20 compounds that elicited an increase or a decrease in the observed ratio of 
compound-treated GFP compared to control GFP from the TIF1p-GFP TIF1p-RFP screen at t=0 
(LHS and RHS respectively). Compounds were only deemed significant if their associated Q values 
were <0.01 (Q value calculation as described in sections 2.2.3.4 and 3.3.1). 
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Figure 5.5:  Whole cell fluorescence intensities of the RFP component of TIF1p-GFP TIF1p-RFP 
treated with the LOPAC library (compounds 1 – 1280) compared against the pooled collection 
of whole cell fluorescence intensities of TIF1p-GFP TIF1p-RFP treated with DMSO  at t=0 (as 
described in section 2.2.3.4). (A) Compound-treated RFP: control RFP for the entire LOPAC library 
ranging from highest to lowest. The top responding compounds that (B) elicited an increase in or 
(C) elicited a decrease in the ratio of compound-treated RFP compared to control. Compounds 
highlighted in B and C are presented in Table 5.4. 
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# Compound 
Compound RFP 
: Control RFP 
Q value 
 
Compound 
Compound RFP 
: Control RFP 
Q value 
1 SB 216763 4.298 0.000494   A-77636 
hydrochloride 
0.6235 0.006794 
2 Metri fudil 1.726 0.002057   Phenamil 
methanesulfonate 
0.6946 0.002572 
3 (±)-Synephrine 1.568 2.21E-07   Diclofenac sodium 0.6967 0.003666 
4 Salmeterol xinafoate 1.509 1.73E-06   9-
cyclopentyladenine 
0.7202 4.213E-05 
5 Tulobuterol 
hydrochloride 
1.498 5.78E-05   CGS-15943 0.7392 5.599E-05 
6 Cyclophosphamide 
monohydrate 
1.348 0.000318   SB 204741 0.7549 0.005417 
7 B-HT 933 
dihydrochloride 
1.316 0.000393   (-)-Cotinine 0.765 0.0008432 
8 Cortisone 1.315 3.58E-07   Oxymetazoline 
hydrochloride 
0.7822 0.0004806 
9 S-5-Iodowillardiine 1.269 0.000972   Pimozide 0.7843 0.002197 
10 Mevastatin 1.26 0.000167   Cephalexin hydrate 0.8174 0.0006399 
11 Bepridil 
hydrochloride 
1.252 0.000934   Clemizole 
hydrochloride 
0.8247 0.008955 
12 (+)-
Brompheniramine 
maleate 
1.193 6.46E-05      
13 SIB 1893 1.185 0.009565      
14 Chlorpropamide 1.172 0.000175      
15 CNS-1102 1.152 0.002102      
Table 5.4: The top compounds that elicited an increase or a decrease in the observed ratio of 
compound-treated  RFP compared to control RFP from the TIF1p-GFP TIF1p-RFP screen at t=0 
(LHS and RHS respectively). Compounds were only deemed significant if their associated Q values 
were <0.01 (Q value calculation as described in sections 2.2.3.4 and 3.3.1). 
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5.2.2 TIF2p-GFP TIF1p-RFP screen 
 
Figure 5.6: Whole cell fluorescence intensities of the GFP component of TIF2p-GFP TIF1p-RFP 
treated with the LOPAC library (compounds 1 – 1280) compared against the pooled collection 
of whole cell fluorescence intensities of TIF2p-GFP TIF1p-RFP treated with DMSO  at t=0 (as 
described in section 2.2.3.4). (A) Compound-treated GFP: control GFP for the entire LOPAC 
library ranging from highest to lowest. The top 20 compounds that (B) elicited an increase in or 
(C) elicited a decrease in the ratio of compound-treated GFP compared to control. Compounds 
highlighted in B and C are presented in Table 5.5. 
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# Compound 
Compound GFP 
: Control GFP 
Q value 
 
Compound 
Compound GFP 
: Control GFP 
Q value 
1 SU 5416 107.5 8.1E-05   Nimustine 
hydrochloride 
0.7959 0.001991 
2 SB 216763 92.35 8.18E-07   8-Bromo-cGMP 
sodium 
0.7993 1.932E-15 
3 Sanguinarine chloride 8.212 1.93E-10   Cefsulodin sodium 
sa lt hydrate 
0.8224 1.799E-05 
4 4-Amino-1,8-
naphthalimide 
6.065 9.58E-07   Rp-cAMPS 
triethylamine 
0.8346 8.788E-08 
5 6,7-ADTN 
hydrobromide 
3.508 3.5E-07   Chlorambucil 0.8456 4.263E-12 
6 Kenpaullone 3.284 0.000892   A-77636 
hydrochloride 
0.85 1.503E-08 
7 Nyl idrin 
hydrochloride 
2.593 2.09E-08   N,N-Dihexyl-2-(4-
fluorophenyl )indole-
3-acetamide 
0.8523 3.417E-10 
8 Idarubicin 2.357 1.06E-06   Cephapirin sodium 0.8533 0.009893 
9 U0126 1.842 5E-06   Tyrphostin 51 0.8549 1.281E-11 
10 Centrophenoxine 
hydrochloride 
1.727 5.81E-06   H-8 dihydrochloride 0.8568 0.002193 
11 Emodin 1.724 2.54E-80   beta-Chloro-L-
a lanine 
hydrochloride 
0.8577 4.586E-06 
12 Papaverine 
hydrochloride 
1.543 1.8E-10   NS 521 oxalate 0.8584 0.009567 
13 Gl ibenclamide 1.413 8.23E-06   Minoxidil 0.8638 3.425E-12 
14 N-(p-
Isothiocyanatophenet
hyl )spiperone 
hydrochloride 
1.394 0.000143   CB 1954 0.8654 0.0007087 
15 LY-367,265 1.356 3.56E-10   L-Tryptophan 0.866 1.619E-13 
16 U-74389G maleate 1.353 1.63E-10   Bromoacetylcholine 
bromide 
0.8663 0.00002 
17 1,3-Dipropyl-7-
methylxanthine 
1.313 9.13E-05   Methapyrilene 
hydrochloride 
0.8674 1.715E-05 
18 SU 4312 1.311 4.93E-13   L-Canavanine sulfate 0.8681 0.002367 
19 GW5074 1.295 2E-12   HA-1004 
hydrochloride 
0.8681 7.045E-05 
20 Tyrphostin 47 1.237 5.04E-14   Oxymetazoline 
hydrochloride 
0.8697 4.962E-06 
Table 5.5: The top 20 compounds that elicited an increase or a decrease in the observed ratio of 
compound-treated GFP compared to control GFP from the TIF2p-GFP TIF1p-RFP screen at t=0 
(LHS and RHS respectively). Compounds were only deemed significant if their associated Q values 
were <0.01 (Q value calculation as described in sections 2.2.3.4 and 3.3.1). 
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Figure 5.7: Whole cell fluorescence intensities of the RFP component of TIF2p-GFP TIF1p-RFP 
treated with the LOPAC library (compounds 1 – 1280) compared against the pooled collection 
of whole cell fluorescence intensities of TIF2p-GFP TIF1p-RFP treated with DMSO  at t=0 (as 
described in section 2.2.3.4). (A) Compound-treated RFP: control RFP for the entire LOPAC library 
ranging from highest to lowest. The top responding compounds that (B) elicited an increase in or 
(C) elicited a decrease in the ratio of compound-treated RFP compared to control. Compounds 
highlighted in B and C are presented in Table 5.6. 
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# Compound 
Compound RFP 
: Control RFP 
Q value 
 
Compound 
Compound RFP 
: Control RFP 
Q value 
1 SB 216763 11.87 7.1E-06   5,7-Dichlorokynurenic 
acid 
0.4047 0.009752 
2 3-Amino-1-
propanesulfonic 
acid sodium 
2.792 1.99E-13   DL-threo-beta-
hydroxyaspartic acid 
0.4762 0.0008282 
3 4-Methylpyrazole 
hydrochloride 
1.75 0.001367   Daidzein 0.4804 0.003666 
4 Apigenin 1.714 0.004848   S(-)-p-
Bromotetramisole 
oxa late 
0.5185 0.0005587 
5 K 185 1.559 0.003201   Des ipramine 
hydrochloride 
0.5364 0.0008234 
6 S(-)-UH-301 
hydrochloride 
1.531 0.001613   Cephalothin sodium 0.5431 0.006875 
7 Nialamide 1.509 0.007601   Ammonium 
pyrrol idinedithiocarb
amate 
0.575 5.414E-07 
8 Buspirone 
hydrochloride 
1.502 3.91E-06   L-Glutamine 0.6081 0.002113 
9 SKF 95282 
dimaleate 
1.493 0.0042   Amantadine 
hydrochloride 
0.6169 0.001555 
10 Mianserin 
hydrochloride 
1.459 0.000147   Spironolactone 0.6308 0.0003674 
11 L-733,060 
hydrochloride 
1.459 0.000244   Ranolazine 
dihydrochloride 
0.6431 0.0002837 
12 8-Cyclopentyl -1,3-
dimethylxanthine 
1.345 7.01E-05   IC 261 0.644 7.879E-05 
13 MJ33 1.295 0.001931   L-Cysteinesulfinic 
Acid 
0.6713 0.008618 
14 Papaverine 
hydrochloride 
1.192 0.000127   (-)-Scopolamine 
hydrobromide 
0.6766 0.008552 
15 (±)-Taxifolin 1.188 0.00263   Fenofibrate 0.7524 0.003196 
16 Tyrphostin 25 1.091 0.001409      
Table 5.6: The top compounds that elicited an increase or a decrease in the observed ratio of 
compound-treated RFP compared to control RFP from the TIF2p-GFP TIF1p-RFP screen at t=0 
(LHS and RHS respectively). Compounds were only deemed significant if their associated Q values 
were <0.01 (Q value calculation as described in sections 2.2.3.4 and 3.3.1). 
 
